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Preface − Engineering Gold Nanorods for Cancer Treatment: 
Biological Profile, Protein Interactions and Drug Delivery 
!!!!!!
Rod-shaped gold nanoparticles, namely gold nanorods (GNRs) have recently attracted a 
widespread attention due to their unique optical properties and facile synthesis. In fact, 
GNRs exhibit two distinct localized surface plasmon resonances (SPRs): the transversal 
mode in the visible region (TSPR) and the longitudinal one in the upper visible or near-
infrared part of the spectrum (LSPR) that correspond to the oscillations perpendicular 
or parallel to the rod length direction, respectively. In particular, the LSPR can be 
tailored to a particular wavelength: there is a linear relationship between the absorption 
maximum of the LSPR band and the mean aspect ratio (AR, ratio between the length 
and the width of the rod) of GNRs, which can be tuned during the synthesis. Other 
factors of impact on the frequencies of both TSPR and LSPR bands are the refractive 
index of the environment and the degree of particle aggregation. In addition, the surface 
of GNRs can be functionalized with a variety of molecules, providing stability and 
biocompatibility. All these features make GNRs ideal platforms for several applications 
and, in particular, for biomedical applications such as sensing, photo-acoustic imaging, 
photothermal treatment of cancer and drug delivery. 
However, several problems are connected to the synthesis and purification of GNRs, as 
well as to their use for biomedical applications.  All these issues are addressed within the 
present PhD thesis, with special attention for GNRs which are well suitable for protein 
sensing, the photothermal treatment of cancer, and the realization of nanocapsules as 
drug delivery systems.  
Specifically, in the Introduction, a brief history of gold nanoparticles and gold 
nanorods, together with the synthetic procedure with an insight into the growth 
mechanism of GNRs, their optical properties and their biomedical applications, are 
addressed.  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In Chapter 1 the issues connected to the most common synthesis of GNRs (e.g. the 
difficulty to obtain relatively small GNRs and the precise control of the LSPR) are 
illustrated. Therefore a simple and reproducible method for the synthesis of small-sized 
GNRs with a good control over the LSPR is reported. 
A modified method for the purification of small GNRs from reaction by-products (i.e. 
spherical and cubic nanoparticles or aggregates) is accurately described in Chapter 2 with 
particular attention to the quantification of the separation. 
Chapter 3 is focused on the realization and characterization of functionalized GNRs for 
therapeutic applications. Although the available literature is inconclusive, particle size 
may modulate critical parameters such as: the cellular penetration, the intracellular 
localization, the biodistribution, features that depend on specific surface area, including 
the rate of interaction with proteins, residual toxicity of contaminants, the ratio between 
absorption and scattering of the particles and the efficiency and stability of 
photothermal conversion. Specifically, this chapter offers an extensive survey on the size-
related biological effects of functionalized GNRs (i.e. PEGylated GNRs), with special 
attention for the cytotoxicity and cellular uptake of  GNRs on a panel of cellular models. 
In Chapter 4, the possibility to tune the interactions between GNRs with proteins is 
illustrated by direct monitoring the LSPR of GNRs, which is highly sensitive to changes 
in the refractive index. In particular, the effect of the insertion of charged groups in 
PEGylated GNRs on their protein interactions is reported, providing useful hints for 
protein sensing applications. 
Finally, in Chapter 5 is focused on the generation of nanosized capsules through self 
assembling of GNRs to be used for the delivery of hydrophobic anticancer drugs. These 
GNR-stabilized nanocapsules could provide highly localized release of anticancer 
therapeutics, maximizing the therapeutic efficacy and minimizing off-target effects. These 
studies could provide the basis for future pre-clinical animal studies that could lead to an 
important new therapeutic strategy for tumors. 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Gold Nanoparticles: from Spherical to Rod-Shaped Gold 
Nanoparticles  !
“The fascination with gold is a story which spans millennia and this metal has played a 
role in almost every human existence. It has been a way of expressing wealth, it has been 
the cause of battles and wars, it has been related to religious devotion, and has been 
linked with our most intimate feelings as a way of expressing love.”[1] 
!
1. Gold Nanoparticles from the Past to the Nanotechnology Era 
Although nanogold represents one of the most remarkable areas of modern nanoscience 
and nanotechnology, spherical gold nanoparticles (GNPs) have been known for millenia. 
The history of GNPs begins in remote times with red ruby glass and reach a peak at the 
end of the seventeenth century.  !
The Lycurgus cup 
The first milestone in the history of gold ruby glass is a Roman opaque glass cup dated to 
the fourth century, the Lycurgus cup, which is exhibited at the British Museum in 
London (Figure 1). This cup shows a green jade color due to the diffusion of light when 
it is illuminated from outside and a deep ruby red one in transmission when it is 
illuminated from inside.  
Figure 1.  The Lycurgus cup illuminated from outside (left), illuminated from inside (right). 
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A detailed analysis of the Lycurgus cup revealed the presence of a small amount of gold 
and silver in the glass. [1] In fact, further analysis by Barber and Freestone in 1980, 
attested the presence of silver-gold alloy of 50-100nm size. [2] Thereafter, Hornyak et al. 
confirmed through a theoretical study that deep red color of the Lycurgus cup due to 
light absorption around 515 nm was consistent with the presence of silver-gold alloy 
particles. [3] However, since there is no evidence that Roman were able to produce aqua 
regia to prepare gold chloride at that period, the hypothesis that the Roman glassmakers 
may have used silver slags without knowing that they also contained gold, thus without 
knowing that gold was the actual colorant of glass, has been proposed. [4] 
!
From the Medieval period to the nineteenth century 
The alchemist of the Middle Ages knew how to produce red-colored glass with gold, 
although samples of such glass have yet to be found. [5] The treatise “Secrets of 
Secrets” [6] of a Persian scholar philosopher and alchemist, Al Razi, reports the earliest 
known written account of a gold ruby glass with the instructions for its preparation by 
heating a very finely powder batch of different elements including gold powder, in a 
closed furnace. However, the philosopher thought he had fulfilled the objective of 
transmutation of “impure” base metals into gold. 
In the fifteenth century, technical informations on gold coloration were discussed in 
“Trattato di Architettura” by Antonio Averlino, also called Filarete, who wrotes “It is also 
said that gold makes colour”.[7] However, according to most of the textbook, the 
production of the red ruby glass did not take place until the end of the seventeenth 
century. The discovery is attributed to Andreas Cassius of Leyden (1685), who produced 
the so-called Purple of Cassius, which is a precipitate obtained from the dissolution of gold 
metal in aqua regia followed by the precipitation of the metallic gold by a mixture of 
stannous and stannic chloride.[8] Alchemists strongly believed that the color of metals 
indicated their essence and that if the color could be extracted it could perform 
alchemical transmutation. Great scientist such as Rober Boyle (1627-1691) and Isaac 
Newton (1642-1727) firmly believed in this principle. 
Johann Kunckel was the first important maker of gold ruby glass in a large scale. 
Thereafter, the art of making gold ruby glass was lost on Kunckel’s death, as illustrated in 
the movie “Hearth of Glass” (Werner Herzog, 1976), and rediscovered in the nineteenth 
century when the interest for glass artefacts swept across Europe and United States. 
!8
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Several English companies exhibited pieces of ruby glass in a variety of less saturated 
colors, close to pale pink, that were obtained by decreasing the gold concentration in 
glass. In the US, gold was also used to produce new types of glass, burmese and rose 
amber glasses, obtained from uranium oxide and gold.[1]  
!
Scientific elucidation of the gold red ruby color 
In nineteenth century, J. C. Fischer of Munich was able to draw up lists of six 
distinguished chemists who held that the gold was in metallic form against twelve who 
believed that it was present as an oxide. [9] As an example, in 1857 Michael Faraday 
delivered his Bakerian Lecture to the Royal Society, ‘Experimental Relations of Gold 
(and other Metals) to Light’, and said that: 
“I believe the Purple of Cassius to be essentially finely divided gold associated with more or less of 
oxide of tin.” [10] 
However, the closest to the truth was Henri Debray, lecturer on chemistry at the Ecole 
Polytechnique, who suggested in a paper to the Académie des Sciences that Purple of 
Cassius consisted of finely divided gold that had been absorbed by stannic acid. [11] Not 
until the turn of the century was the true nature of Purple of Cassius elucidated. Richard 
Zsigmondy, a Viennese chemist who had spent some years studying gold colors at the 
Schott Glassworks in Jena, in 1905 published his researches on colloidal golds.[12] 
Thanks to the development of a slit ultramicroscope, based on light scattering, he was 
able to observe finely divided gold particles on colloidal stannic acid, and confirmed the 
presence of colloidal particles in the ruby glass. For these investigation he was awarded of 
the Nobel Prize in Chemistry in 1925. [12] 
In 1908 Gustav Mie predicted the optical properties of homogeneous spherical particles 
[13]: for a spherical nanoparticle much smaller than the wavelength of light, an 
electromagnetic field at a certain frequency induces a resonant, coherent oscillation of 
the metal free electrons across the nanoparticle. This oscillation is known as the localized 
surface plasmon resonance. [14-15] The plasmon oscillation of the free electrons of the 
metal particles Au, Ag and Cu, results in a strong enhancement of absorption and 
scattering of electromagnetic radiation in the visible range (i. e. around 520 nm for gold) 
in resonance with the plasmon frequency, giving them intense colors and interesting 
optical properties, with the ratio between scattering and absorption related to the 
!9
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particle volume. This is more intensively discussed in the next section of the present 
chapter. 
Therefore, the dichroism of the Lycurgus cup, can be explained as follows. When the cup 
is illuminated from outside, the green color is due to the non-negligible contribution of 
the scattering of the 50-100 nm nanoparticles contained in the cup, while the red color 
when the cup is illuminated from inside results form the absorption contribution. 
In Carbert's paper [16] the chemical approach to the formation of the Purple of Cassius is 
reported. Two distinct stages are involved, first the formation of a gold sol and then its 
stabilization. The first stage is a redox reaction in which the addition of a stannous 
chloride solution to an auric chloride solution results in the formation of metallic gold: 
2Au3+ + 3Sn2+ → 2Au0 + 3Sn4+ 
It is most important that particle growth should be controlled during this reaction, 
which proceeds very rapidly. Transmission electron microscopy of enamels colored by 
good quality Purple of Cassius indicates that the gold particle’s optimum size was 10-15 
nm (Figure 2). 
Figure 2. Examination of Purple of Cassius by transmission electron microscopy shows the black 
particles of finely dispersed gold on the surface of colloidal stannic acid. (Magnification: x 
100000). 
However a large number of factor can cause variations in the particle’s size and therefore 
in the hue and strength of the color. 
A simplified scheme of the principle of gold ruby glass formation is reported by Weyl.[17] 
The preparation of gold ruby glass consists of three steps: 1) the addition of gold 
(hundreds of ppm) as gold chloride or as Purple of Cassius, in melt glass; 2) a step of rapid 
quenching to room temperature; 3) a step of annealing at 500-650°C, during which red 
color appears. Specifically, during the cooling step, there is oversaturation of the 
!10
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“atomic” gold solution and the formation of gold nuclei. At this point, two distinct cases 
can be distinguished depending on the composition of the glass: 1) glass such as sodium 
silicate or borax glass lead to the growth of the nuclei and the formation of large gold 
nanoparticles (100 nm) and a brownish color; 2) the presence of tin or bismuth ions in 
glass enhances gold solubility, and when nuclei are produced, a substantial amount of 
gold still remains in atomic dispersion. Then, reheating causes the nuclei to grow and 
nanoparticles with size 5-50 nm are formed, giving rise to the red color. 
!
Gold nanoparticles today 
The history of GNPs, that has paralleled that of gold ruby glass for centuries, is now 
expanding with the advent of Nanosciences and Nanotechnologies.  
The “golden timeline” (Figure 3) summarizes the most relevant recent advances in 
chemistry, physics and microscopy, which have led to better control of GNPs size and 
shape distribution and a deeper understanding of how GNPs interact with light, other 
than more details on their atomic structure. 
Figure 3. The golden timeline: major events and discoveries from the invention of the electron 
microscope until recent days. [18] 
Nowadays researches on synthesis and the discovery of anisotropic GNPs, as well as on 
their properties and applications, involve many fields in chemistry, biology and physics.  
!11
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More details on these topics will be discussed in the next sections, with a special 
consideration for rod-shaped gold nanoparticles, namely gold nanorods (GNRs), their 
unique optical properties, their preparation and their biomedical applications.  
!
2. Optical properties of spherical and rod-shaped gold nanoparticles 
Among the remarkable properties of GNPs, the collective behavior of their conduction 
electrons that give rise to the plasmon resonance is a dramatic one. The intriguing 
optical properties of GNPs, as reflected by their intense color, are attributed to their 
unique interaction with incident light. In fact, in the presence of the oscillating 
electromagnetic field of light, the conduction band electrons of a GNP undergo a 
collective coherent oscillation in resonance with the frequency of light, which is called 
Localized Surface Plasmon Resonance (localized SPR). [13,19-21] The oscillation induces 
a charge separation between free electrons and the ionic metal core, creating a field 
inside the GNPs, the so-called restoring field, but also out of the nanoparticles. Due to 
the large charge accumulation at the surface of GNP, intense fields are generated in a 
region larger than the nanoparticle size. 
Figure 4. Illustration of the electric field of the light inducing the movement of conduction 
electrons which accumulate at the GNP surface (left) and the electric fields of incident light and 
that created by the electron oscillations near the GNP (right). [22] 
As illustrated in Figure 4, there are wide regions where the electric field created by the 
nanoparticle is opposite to that of the light, so the interference is destructive, leading to 
light absorption beyond the NP volume [23], as seen in the UV-vis spectrum, which is 
the origin for the observed color of GNPs (Figure 5).  
!12
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For other regions, the result of the interference between both electric fields is a net field 
with a different propagating direction, hence inducing light scattering. Therefore, the 
interaction of light with matter containing GNPs invariably involves scattering and 
absorption, both of which cause attenuation in the intensity of beam passing through 
the medium. [22]  
Figure 5. Extinction spectrum of GNPs with 40 nm size. For GNPs, the contribution to the 
extinction of interband transitions and localized SPR are resolved. [22]  !
Moreover, the localized SPR condition is dependent on the particle size, shape, structure, 
dielectric properties of the surrounding medium, and the plasmon coupling between 
particles, as these factors affect the electron charge density on the particle surface. 
[13,19-21,24-26]  
Effect of the shape: GNRs 
While spherical GNPs show a strong localized SPR band in the visible region, 
anisotropic GNPs, also exhibit a red-shifted localized SPR band compared to their 
spherical analogs. [27-28] The most clear example of these shape effects are the GNRs 
(Figure 6). [29-30]  
Figure 6. Transmission electron microscopy (TEM) images of different GNRs. Scale bars: 100nm. 
[31] 
!13
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Gold nanorods with cylindrical symmetry usually exhibit two plasmon modes, a 
longitudinal (localized) SPR  (LSPR) mode associated with the electron oscillations along 
the length direction and a transverse (localized) SPR (TSPR) mode arising from the 
transverse electron oscillations. Due to the longer path of the electron movements, the 
longitudinal mode is located at the red side of the transverse one (Figure 7). In fact, the 
charge accumulation will be the maximum for the transversal plasmons and the 
minimum for electron displacement along the rod axis. The restoring force is 
proportional to this charge accumulation, therefore, for electron oscillating along the rod 
axis, smaller forces and, consequently smaller resonance frequencies (i.e. larger resonant 
wavelengths) should be expected.  
Figure 7. Illustration of the electric field of the light inducing the movement of transverse and 
longitudinal conduction electrons which accumulate at the GNR surface (left) and a 
representative extinction spectrum of GNRs (right). [31]  
Therefore, for GNRs, the resonant frequency  of the TSPR falls about the same position 
as for spherical GNPs while the resonance of LSPR shifts toward larger wavelengths 
when the nanorod aspect ratio (AR), the ratio between the length (l) and the width (w) of 
the rod, increases (Figure 8). 
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Figure 8. Tunable optical properties of GNRs by changing the ARs. Gold nanorods of different 
ARs exhibit different dimensions as seen by TEM (A), in different color (B) and different SPR 
wavelengths (C). [32] 
!
This optical behavior can be well understood according to Gans theory [33] which was 
developed for the explanation of optical properties of ellipsoid particles based on the 
dipole approximation. In aqueous solution, the SPR absorption maximum (λmax) is 
linearly proportional to the AR of the rod by the following relationship:  
λmax= (95AR+420) nm [34-37] 
This provides the possibility of optical tuning GNRs by simply varying the AR of the rod, 
which is different from spheres for which the SPR only slightly red-shifts with increasing 
particle size. [22] The AR of GNRs can be easily tuned by varying the ratio between 
reagents used for the synthesis; a more detailed explanation is reported in the next 
section.  
Gans theory also enables the determination of the statistical distribution of ARs of a 
GNRs solution with a convolution of homogeneously broadened spectra of GNRs, each 
with a specific AR and population contributions. [38] Such a method provides a relative 
convenient alternative to conventional TEM. 
!
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Effect of the surrounding medium 
As mentioned above, the SPR and, in particular, the LSPR of GNRs, is also significantly 
dependent on the surrounding medium because the dielectric function of the 
surrounding medium (εm) determines the light wavelength at the vicinity of the GNR, 
altering the geometry of the electric field at the surface of the particle. However, the 
most important effect is related to the polarization of the medium. In fact, during the 
SPR excitation, the charge accumulation creates an electric field in the vicinity of the 
GNRs, in addition to that of the incident light. This field induces the polarization of the 
dielectric medium, resulting in a charge accumulation at the interface between the 
dielectric and the GNRs) that will partially compensate the charge accumulation due to 
the movement of conduction electrons in the GNR. This reduction of charge will 
depend on the εm; the larger εm, the larger the polarization charge, and hence, the larger 
the effect on the SP. Reducing the net charge at the NP surface implies a reduction in 
the restoring force. For an oscillator, it is well known that reducing the restoring force 
leads to smaller resonant frequency. [22] Thus, increasing the dielectric constant of the 
surrounding media will shift the SPR band towards larger wavelengths (Figure 9), 
according to the following equation: 
λmax= (33.34 εm AR−46.31 εm + 472.31) nm  [34] 
Figure 9. Example of the effect of the medium on the LSPR of GNRs. [39] (A) Normalized 
extinction spectra of GNR with an aspect ratio of 4.6 in water-glycerol mixtures of varying 
compositions. The arrow indicates the direction of increasing volume percentage of glycerol in the 
liquid mixture. (B) Dependence of the longitudinal plasmon shift on the refractive index of the 
liquid mixture. 
!16
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Effect of the plasmon coupling 
GNRs display unique and strongly enhanced optical properties due to the TSPR and 
LSPR. When two GNRs are placed in a close proximity to, but not in contact with each 
other, the plasmon resonances carried by the two nanorods will interact (i.e. near-field 
interaction) to form different collective plasmon modes (coupled plasmon resonance 
modes), according to the plasmon hybridization model. [40]  
Due to the geometrical anisotropy and the synthetically tailorable longitudinal plasmon 
energy of GNRs, coupled GNRs exhibit extremely rich spectral responses. The plasmon 
coupling of GNRs also provides much larger electric field enhancements than individual 
GNRs. These unique properties brought by coupled plasmonic GNRs offer great 
potential in a variety of applications, such as highly sensitive biological and chemical 
sensors [41], optical switches [42], plasmon enhanced spectroscopies (e.g Surface-
Enhanced Raman Spectroscopy, SERS) [43], and metamaterials for manipulating light at 
the nanoscale.[44]  
Both theoretical and experimental results have revealed that the plasmonic interactions 
between two GNRs depend strongly on their relative configurations.[45-48] Under the 
excitation of light polarized along the length axis of GNRs, linearly, end-to-end 
assembled GNRs homodimers have been experimentally found to support a largely red-
shifted coupled plasmon mode (Figure 10), while side-by-side assembled homodimers 
support a slightly blue-shifted coupled plasmon mode (Figure 11).[49] 
Moreover, as illustrated in Figure 10 and 11, there is a relationship between the 
internanorod distance and the plasmon coupling. A universal scaling behavior of the 
distance-dependent decay of the plasmon coupling, which is expressed by the fractional 
wavelength shift after coupling, is applicable for GNR homodimers aligned along the 
length axis when the gap distance is not very small. The universal scaling behavior can be 
described by the following equation: !!!
where, l is the plasmon wavelength of the uncoupled GNR, Δλ is the plasmon 
wavelength shift caused by the plasmon coupling, s is the gap distance, D is the length of 
GNR, t is the decay constant, and A is the maximal fractional plasmon wavelength shift.
[50] 
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Figure 10. DDA-simulated extinction efficiency spectra of GNR (80x20 nm) assembled in an end-
to-end orientation: (a)LSPR excitation and (b) TSPR excitation of a pair of nanorods as a 
function of the internanorod center-to-center distance (R= 282, 121, 91, 83 nm and 81 nm where 
GNRs touch each other). (c) LSPR excitation and (d) TSPR of a nanorod assembly as a function 
of the number of GNRs with R fixed at 83 nm.[45] 
Figure 11. DDA-simulated extinction efficiency spectra of GNRs (80x20 nm) assembled in a side-
by-side orientation: (a) LSPR excitation and (b) TSPR excitation of a pair of GNRs as a function 
of R=120, 60, 30, 22 nm and 20 nm where GNRs touch each other. (c) LSPR excitation and (d) 
TSPR of a nanorod assembly as a function of the number of GNRs with R fixed at 22 nm.[45]  !
!18
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3. Synthesis and mechanism of GNRs formation 
Shape-controlled synthesis has received widespread interest due to the importance of 
anisotropic GNPs in their structural, optical, electronic and catalytic properties, as well 
as their potential applications (a more detailed description on the applications is given in 
section 5). Although  the modern synthesis of spherical GNPs is dated back to 1857 by 
Faraday [51] fabrication of colloidal GNRs emerged only in 2000s [52] and great 
advancement has been achieved for obtaining GNRs with high yield, quality, and 
uniformity. [53,54]  
The most common synthesis of GNRs involves nucleation and growth steps (i.e. seed-
mediated growth method). Modern concepts of seed-mediated synthesis were established 
by the Murphy research group in 2001. [51] They reported the synthesis of GNRs by the 
addition of citrate-capped GNPs to an Au(I) growth solution generated by the reduction 
of Au(III) (i.e. tetrachloro auric acid, HAuCl4) with ascorbic acid (AA) in the presence of 
hexadecyltrimethylammonium bromide, also called cetyltrimethylammonium bromide 
(CTAB) and Ag(I) (from silver nitrate, AgNO3) . The seeded-growth method has become 
established as the most efficient and popular one to synthesize specific shapes in high 
yields.[52,53] In 2003, Nikoobakht and E-Sayed [53] made two modifications to this 
method: replacing sodium citrate with a stronger stabilizer (i.e. CTAB) in the seed 
formation process and utilizing silver ions to control the AR of GNRs. This protocol 
includes two steps (Figure 12): 1) synthesis of seed solution by the reduction of HAuCl4 
in the presence of CTAB with ice-cold sodium borohydride (NaBH4) and 2) the addition 
of the seed solution to the Au+ stock solution in the presence of CTAB and AgNO3 
which is obtained by reduction of HAuCl4 with AA. AgNO3 is introduced  to the gold 
solution before seed addition to facilitate the rod formation and to tune the AR as well. 
This method produces high yield GNRs (>95%) with AR ranging from 1.5 to 5. 
Figure 12. Scheme of the seed-mediated synthesis by Nikoobakht and E-Sayed [53] and chemical 
structure of CTAB. 
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One of the key points in the seeded growth method is the use of a weak reducing agent, 
such as AA,  so that gold reduction takes place only on existing nuclei in solution, which 
also act as catalysts. Upon addition of AA to a growth solution containing a mixture of 
HAuCl4 and CTAB, the reduction of Au(III) to Au(I) takes place, indicated by the 
solution turning colorless (the ligand-to-metal charge-transfer band disappears for a d10 
metal center as Au(I)). It is crucial that the reducing agent cannot complete the reduction 
of Au(I) into Au(0), that is, secondary nucleation during the growth step is prevented. In 
fact, the seeds act as catalysts for the final reduction step, thereby inducing reduction of 
the Au(I) precursor on their surface only. The proposed mechanism consists in an in situ 
reduction of Au(I) catalyzed by the Au(0) surface of seeds, which drains electrons from 
the reductant. [55] It should be noted that AA features a pH-dependent reduction 
potential, being lower under acidic conditions and higher at more basic pH values, [56] 
which has been applied to modulate Au nanorod growth. In fact, if the pH is above 9, 
ascorbic acid will be able to reduce Au(I) into Au(0), even in the absence of seeds, thus 
compromising the seeded growth mechanism. 
Figure 13. Schematic representation of crystallographic faces of gold seeds and the CTAB bilayer 
on GNRs surface during the growth mechanism. 
The proposed mechanism to explain the growth process of GNRs consists in a 
surfactant-preferential-binding-direct growth (Figure 13) [57], in which CTAB adsorbs 
onto GNRs in a bilayer fashion, with the CTA+ headgroups of the first monolayed facing 
the gold surface, and preferentially binds to the {110} crystallographic faces of gold 
existing along the sides of GNR, as compared to the {100} faces at the tips. 
Consequently, the crystal growth on the side of GNRs is retarded and gold is deposited 
to the end facet leading to rod growth. [57-58] 
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Moreover, the effect of AgNO3 is crucial for GNRs growth. In fact, the role of silver ions 
in controlling the AR can be explained as adsorption of the Ag-Br pair to the different 
facets of GNRs which restricts particle growth. [52] Ag-Br pairs decrease the charge 
density of bromide ions and thus decrease the repulsion of neighbouring CTA+ 
headgroups. [53] Liu and Guyot-Sionnest [58] have systematically studied the effect of 
silver ions on CTAB-capped seeds, showing that these seed lead to single crystalline 
GNRs with  {110} faces on the side and {100} faces at the flat end. The deposition of gold 
atoms on the seed surface does not create a stacking default and, therefore, preserves the 
initial seed structures. Although Ag(I) in the CTAB solution cannot be reduced to bulk 
silver atoms by AA in acidic pH [59], it can be reduced to Ag(0) onto a gold substrate in 
the form of a metal monolayer at a potential lower than that one required for a bulk 
reduction, known as underpotential deposition (UPD). [60] The reduction potential for 
silver deposition on {110} gold faces is lower than that on  {100}. [60] Therefore the silver 
deposition on the {110} side of the rod is faster than on the {100} ends due to the UPD 
effects and thus the seeds grow into nanorods. In fact, an increase in silver ions results in 
an increase of the AR (Figure 14) [61]. However, an increase in silver ions over a 
threshold  concentration could not further increase the AR due to the blocking of the 
end facet on the nanorods by silver metal deposition. [53] 
Figure 14. Increasing the amount of silver ions leads to GNRs of higher aspect ratios, which is 
consistent with the red-shifting LSPR. For GNRs with AR over than 5, the use of binary 
surfactant is required. [61] 
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The synthesis of Au nanorods relies on the ratios between all reagents involved. For this 
reason, the allowed range for each component is quite narrow and multiple parameters 
must be take into account [62], as briefly summarized below: 
− [Ag(0)]: A higher concentration increases the aspect ratio. [63] 
− [ascorbic acid]: A higher concentration decreases the aspect ratio. [63] 
− [seed]: A lower amount of seeds results in the production of larger nanorods, in 
general with a smaller AR. [64] 
− [pH]: Lower pH values slow down the growth kinetics, leading to higher ARs. [65] 
!
4. Functionalization of GNRs 
The production of GNRs requires the use of CTAB, which acts as a stabilizing agent for 
GNRs [66] and is evidently present  after synthesis, both in the supernatant and on the 
surface of GNRs. In fact, the capping CTAB molecules form a partially-interdigitated 
bilayer on the surface of GNRs, similar to the structure of a vesicle (Figure 16). The gold 
surface is believed to carry negative charges due to the adsorption of bromide ions. The 
positively charged ammonium headgroup of CTA+ binds tightly  to the gold surface 
through electrostatic interaction, leading to the formation of the inner layer. Since the 
hydrophobic carbon-chain does not like to stay in water, another layer of CTAB 
molecules is formed, with the hydrophobic tails pointing inside and interacting with 
dose of the inner layer and the ammonium groups pointing outside. [67] The CTAB 
bilayer makes GNRs positively charged and therefore stabilized in aqueous solutions. 
However the bilayer can be disrupted when the CTAB concentration is lower than its 
critical micelle concentration (cmc= 1 mM at 25°C) [68], organic solvents (able to 
dissolve CTAB) are added, the salt concentration in the solution is high, or some 
external stimuli are applied to the GNRs solution. [50] Moreover, CTAB is a cationic 
surfactant that is also known to be a detergent suitable for the degradation of 
biomembranes and peptides. Therefore, free CTAB is certainly cytotoxic to human cell. 
(Figure 15). [69]  
In order to make GNR biocompatible and stable under different conditions and arm 
them with added functionalities for particular applications, CTAB-capped GNRs should 
be functionalized with appropriate organic or inorganic species. [70] Different methods 
have been developed for functionalizing CTAB-capped GNRs end almost completely 
remove CTAB from GNR surface. 
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Figure 15. Viability of cells incubated with CTAB-capped GNRs and PSS-coated GNRs, 
compared to free CTAB at different concentrations. [69] 
Gold-thiol bonding chemistry is commonly used for completely or partially 
functionalizing the surface of GNRs. Small molecules are not preferred because the steric 
effect introduced by small molecules cannot overcome the large attractive force among 
GNRs. Therefore, the bonding of small thiol molecules often leads to poor dispersibility 
and irreversible aggregation of GNRs. Thiol-terminated polymers with high molecular 
weight, such as (5000 MW)-polyethylene glycol (PEG) is perceived as the coating of 
choice because of its biocompatibility, ability to avoid the detection from macrophages, 
readiness of biochemical modification, such as with antibodies, and steric hindrance 
against particle aggregation. [71-73] 
Figure 16. Illustration of the CTAB bilayer on GNRs surface and the two-step procedure for the 
complete detoxification of GNRs from CTAB. [68] 
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Moreover, thiol molecules have been found to preferentially bind to the two ends of 
GNRs at low concentrations, which has been attributed to the smaller packing density of 
CTAB at the highly curved ends. [74-75] Kinnear et al. [68] reported a protocol for the 
complete detoxification of GNRs from CTAB with a two-step procedure, achieved with a 
primary functionalization with thiol-PEG in water, during which PEG is preferentially 
bound to the two ends of the rod, and, thereafter, a second functionalization step in 
ethanol, in which CTAB is highly soluble (Figure 16). 
Other coatings have been proposed as an alternative to PEG, such as other polymers 
[69], hydrophobic thiol-molecules [76] or coating with silica. [77] However PEG remains 
the most common choice of functionalization. !
5. Biomedical applications of GNRs 
As mentioned above, GNRs provide exceptional optical properties, which make GNRs a 
new type of nanostructure suitable for a wide range of biological and biomedical 
applications including biosensing, biomedical imaging, gene and drug delivery, disease 
detection, diagnosis and therapy. In the next paragraphs an introduction to some of the 
most important applications of GNRs is given.  !
Photothermal treatment of cancer 
The photothermal treatment of cancer that relies on the plasmonic photothermal 
conversion of GNRs, promotes the selective destruction of cancer cells without using any 
conjugated drugs by inducing local heating (up to 47°C) of targeted sites. [78] In this 
frame, GNRs exhibit an intense and tunable absorption in the near IR region (LSPR) of 
the spectrum (650-1000 nm), where light penetration in tissues is optimal due to 
minimal absorption by water and hemoglobin in the tissue. Therefore, GNRs are able to 
efficiently convert light (from laser irradiation) in localized heat. [79] In addition, the 
conjugation of targeting molecules, such as  folate, or antibodies to GNRs may allow a 
pin-point targeting of heating. As an example, Huff et al. [80] and Tong et al. [81] have 
characterized the mechanisms of cell injury due to the photothermal effect of folate-
conjugated GNRs (F-GNRs) on KB cells at the single-cell level, using a scanning laser 
microscope. KB cells with membrane-bound F-GNRs, showed the loss of membrane 
integrity after laser irradiation (Figure 17). !
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Figure 17. Site-dependent photothermolysis mediated by folate-coniugated GNRs(red). KB cells 
with membrane-bound F-NRs before (A) and after (B) laser irradiation. The loss of membrane 
integrity was indicated by ethidium bromide (EB) nuclear staining (yellow). [81] !
Molecular imaging 
Molecular imaging is defined as “ a tecnique which directly or indirectly monitors and 
records the spatiotemporal distribution of molecular and cellularprocesses for 
biochemical, biologic, diagnostic, or therapeutic applications”. [82] It visualize molecular 
or genetic phenomena in live cells, tissue, organs, and whole organisms. [83]  
Plasmonic nanoparticles such as GNRs, are efficient contrast agents in optical imaging 
based on their unique light-particle interaction process (i.e. the excitation of localized 
SPR by light). This SPR enhances all linear and nonlinear optical properties and thus 
offers multiple imaging modalities including light scattering, [84] optical coherent 
tomography, [85] extinction, [86] photothermal, [87] two-photon luminescence, [88] 
multiphoton imaging, [89] and photoacoustic imaging. [90] Some examples of in vitro 
and in vivo imaging are illustrated in Figure 18 and 19. 
Figure 18. Dark-field scattering image of cancerous hematopoietic stem cells with anti-EGFR-
conjugated GNRs located on cytoplasm membranes (A).[78] Two-photon-excited 
photoluminescence imaging of KB cancer cells with internalized folate-conjugated GNRs (B). [91] !
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Dark field microscopy is a particularly suitable method for imaging biological samples: 
although the extinction cross section of GNRs is dominated by absorption, the amount 
of scattering produced is more than sufficient for single-particle detection against a dark 
background. By using dark-field scattering imaging, antibody-labelled GNRs have been 
demonstrated for cancer diagnosis by their selective binding to cancer cells through 
recognition of the over-expressed EGFR on the cell surface (Figure 18A). [78] Moreover 
two-photon-excited photoluminescence of GNRs can well differentiate their targeting of 
cancer biomarkers on cytoplasm membranes (Figure 18B). [91]  
Photoacoustic tomography (PAT) is a noninvasive imaging technique based on NIR-
induced photoacoustic effects. [92] NIR-absorbing GNRs have recently been employed as 
contrast agents for PAT, which would otherwise rely on the intrinsic differences in 
optical absorption within tissue for contrast. PAT images of nude mice were significantly 
enhanced by the injection of GNRs, which could enhance differences in signal intensity 
with concentration gradients as low as pM concentrations (Figure 19). [93] 
Figure 19. GNRs as contrast agents for photoacoustic tomography. PAT image of a nude mouse 
(white outline) before (A) and after (B) injection of GNRs. [93] 
 
Biosensing 
As described previously, the LSPR frequency of GNRs depends on the dielectric 
constant of the surrounding medium: an increase of this constant leads to a red-shift of 
the LSPR wavelength. Therefore, the LSPR wavelength, either by absorption or 
scattering, provides great opportunity to monitor the changes of the local environment 
of GNRs and thus can be used for sensing. [94] In particular the sensitivity, defined as 
the plasmon shift per refractive index unit change depends on the shape of the 
nanoparticles: anisotropic nanoparticles such as GNRs give higher sensitivity than 
spherical one. Several examples  with antibody-conjugated GNRs have been reported.  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Chilkoti et al. successfully detected the binding of streptavidin to an individual bioting-
conjugated GNRs with a detection limit down to 1 nM, by measuring the plasmon shift 
of the LSPR of GNRs. [95] An alternative strategy for plasmonic sensing is to make use 
of the aggregation or assembly of GNRs. It is based on the spectral shift due to the 
plasmon coupling by bringing different GNRs close to each other. As an example GNRs 
have been utilized for environmental toxin sensing by employing their side-by-side and 
end-to-end assemblies. [96] In this study, GNRs were first functionalized with 
microcystin-LR antibodies and microcystin-LR-OVA antigens to induce the side-by-side 
or end-to-end assembly (Figure 20A). An increase of the toxin MC-LR concentration in 
the solution broke the conjugation between the MC-LR antibodies and antigens, leading 
to the disassembly of the nanorods. By monitoring the spectral change of the GNRs 
solution, the presence of the toxin as well as its concentration can be measured (Figure 
20B). The sensitivity of the end-to-end assembly modality reaches up to 0.03 ng mL-1.  
Figure 20. Schematic showing the toxin detection method with side-by-side and end-to end Au 
nanorod assemblies.[96] (F) Evolution of the extinction spectra of GNRs as the concentration of 
microcystin-LR (MC-LR) is increased for the end-to-end assemblies. [96] (G) Schematic showing 
the detection of Hg2+ with GNRs.[97] (H) Spectral evolution of GNRs as a function of the Hg2+ 
concentration. The red arrow indicates the spectral change with the increase in the Hg2+ 
concentration. [97] 
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The plasmonic sensing principle can also be extended for nonbiological species such as 
Hg2+ ions in tap water by taking advantage of the amalgamation of mercury with gold. 
[97] The adsorbed Hg2+ ions amalgamate with GNRs, leading to the reduction of the AR 
(Figure 20C). Therefore, the concentration of Hg2+ ions can be determined from the 
blue shift of the longitudinal plasmon resonance of the nanorods (Figure  16D). !
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* Unpublished results from a work in collaboration with Dr. Chang Soo Kim and Prof. V. 
M. Rotello (University of Massachusetts, Amherst) !
Graphical abstract 
!
1. Introduction 
Rod-shaped gold nanoparticles, namely gold nanorods (GNRs) have received a great 
attention in recent years due to their unique plasmonic properties. In fact, GNRs exhibit 
two distinct localized surface plasmon resonance (SPR): the transversal mode in the 
visible region  (TSPR) and the longitudinal one in the upper visible or near-infrared part 
of the spectrum (LSPR) that correspond to the oscillations perpendicular or parallel to 
the rod length direction, respectively. [1] The LSPR can be tailored to a particular 
wavelength [2]. There is a linear relationship between the absorption maximum of the 
LSPR band and the mean aspect ratio (AR, ratio between the length and the width of 
the rod) of GNRs, which can be tuned during the synthesis [3]. 
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The size and AR are the primary factors that determine the optical properties of GNRs 
(including the technological relevant phototermal aspects), and their surface reactivity.[4]  
In the synthesis of GNRs, control over the size and AR has been one of the most 
important and challenging tasks. [5] In particular, several modifications of the seed-
mediated growth method by Nikoobakht et al. [3,6,7] have been reported to synthesize 
GNRs of different AR and with a width greater than 8 nm and length depending on the 
silver ion content [8]. However, with these methods it is difficult to synthesize small sized 
GNRs while there is an increasing demand of small sized GNRs for medical applications 
because of their high-payload-to carrier ratio (e.g. drug delivery) [9] and  their clearance 
in in-vivo studies [10]. More recently, a seedless growth technique has been published by 
M. A. El-Sayed et al. [11], describing a one-step synthesis of GNRs with low dimensions 
and AR by direct reduction of Au(III) ions with NaBH4. The key factor of this synthesis 
to obtain different size of GNRs is the concentration of NaBH4 used in the growth 
solution. However, since the critical step of this synthesis is the concentration of NaBH4 
which is added to the unstirred solution, only few millilitres (10-15 ml) of GNRs can be 
synthesized. In fact, when NaBH4 is added to a higher volume of the solution, a gradient 
of concentration occurs and the growth of GNRs is not homogeneous.  
Moreover, the common issue of all the synthetic procedures is the reproducibility of the 
synthesis. Specifically, since the LSPR of GNRs is highly sensitive to small changes of the 
AR it is difficult to synthesize two batches of GNRs with the same wavelength of the 
LSPR with a good control. 
Therefore, several methods have been proposed to decrease the length of GNRs after 
synthesis, through a selective oxididation of the ends of GNRs by addition of oxidizing 
agents such as FeCl3 [12], H2O2 [13] or through the combination of a lower pH and a 
higher temperature [14]. However, in all these cases small sized GNRs have never been 
obtained.  
In the present chapter a method for the selective shortening of GNRs to produce small-
sized nanorods with a good control over the LSPR is illustrated. !!!!!!
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2. Results 
Synthesis of small GNRs with tunable AR 
The synthesis of small gold nanorods with tunable length (and AR) was performed 
following the seeded growth method according to Nikoobakht et al. [3] and Ratto et al. 
[6] with slight modifications. Shortly, the idea was to synthesize GNRs with a higher AR 
and, thereafter, selectively oxidize GNRs in situ to obtain GNRs with tunable length. 
Firstly, the synthesis was modified increasing the amount of seeds injected in the GNRs’ 
growth solution as well as the amount of silver nitrate (AgNO3). In fact, it is well known 
that an increase of AgNO3, as well as the amount of seeds results in an increase of the 
AR (and a smaller width). [15] Figure 1 reports the extinction spectra and TEM images 
of GNRs obtained by adding 9 times more seeds than the normal synthesis [6] and 
different concentrations of  AgNO3. 
Figure 1. Extinction spectra and TEM images of GNRs obtained with AgNO3 50 μM (A) or 92 
μM (B). 
GNRs synthesized with a lower amount of silver nitrate showed AR of 3.9 ± 0.8, with a 
width of 7.5 ± 1.0 nm and length of 28.6 ± 3.5 nm (LSPR at 789 nm), while the AR of 
GNRs obtained with a higher content of AgNO3 was 4.8 ± 0.5, the width 6.3 ± 0.9 and 
length 30.1 ± 4.8 (LSPR at 860 nm). It is evident that an increase of silver nitrate results 
in GNRs with a higher AR but similar length and thinner width, as reported in 
literature [3]. Therefore a selective shortening through oxidation of GNRs with AR 4.8 
would results in GNR with a lower AR and length but similar width.  
To perform the selective oxidation of GNRs a 250 ml glass bottle used for GNRs’ 
synthesis was treated with freshly prepared aqua regia (details are reported in the 
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Experimental Section), then washed 10 times with milli-Q water and used immediately 
for GNRs synthesis and successive oxidation. GNRs synthesized and stored in this 
treated glass bottle showed a considerable change in the extinction spectra.  
!
Figure 2.  Time course extinction spectra of GNRs during the oxidation. 
!
Figure 2 shows the extinction spectra of GNRs acquired after 30 minutes from the seeds 
injection in the growth solution and every 24 hours for one week. GNRs after 30 
minutes exhibit two extinction bands corresponding to the longitudinal and transversal 
plasmon resonances, respectively at 860 nm and 510 nm. Thereafter, the oxidation of 
GNRs by NOCl adsorbed on the glass surface of the glass container occurred. 
During the oxidation a time-dependent blue-shift and a decrease of the intensity of the 
LSPR was detected, while the TSPR remains approximately at 510 nm, indicating a 
lowering of the AR of GNRs [4].  
!
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TEM images of three samples collected during the oxidation  showed that after 30 
minutes the LSPR of GNRs was at 860 nm with a size of (29.5±5.2 × 6.1±0.9) nm and 
AR 4.8±0.6 (Figure 3A), after 48 hours the LSPR was at 795 nm, the size 
(21.0±3.5×5.5±0.5) nm and AR 3.8±0.6 (Figure 3B), and after 72 hours the LSPR was at 
755 nm, the size (17.1± 2.8 ×5.0± 0.5  ) nm and AR 3.4 ± 0.4   (Figure 3C). 
Figure 3.  TEM images of GNRs collected after 30 minutes (A), 48h (B) and 72h (C) from seeds 
injection in the growth solution. Scale bar: 100nm 
Figure 4. Extinction spectra of GNRs collected after 48h and stored in a plastic container. 
Spectra are recorded immediately after the synthesis (sample B) and after 1 week.  
!
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Moreover, after one week, when the oxidation process reached completion, the solution 
was colorless, indicating the presence of Au(I) and not Au(III) ions in solution. 
Thereafter, the possibility to scale up the synthesis was tested, performing the synthesis 
in a 1l glass bottle with 500 ml of growth solution. GNRs with similar size of the smaller 
batch were obtained. Figure S1 and Figure S2 illustrate, respectively, the TEM images 
and the extinction spectra of GNRs collected in two different stage of the process. 
Interestingly, samples collected during the oxidation and stored in plastic containers did 
not show significant changes in the extinction spectrum during the time, indicating that 
the speed of the oxidation was significantly reduced. Figure 4 shows the changing of the 
spectra of sample B (GNRs collected after 48h) stored in a plastic container during one 
week: only a 10 nm blue-shift of the LSPR was detected, while the TSPR did not show 
any changes. 
!
Tuning the speed of the oxidation 
In order to tune the speed of GNR’s oxidation in the glass bottle, the number of 
washing cycles with milli-Q water was changed. Specifically, the time course of the 
extinction spectra of GNRs synthesized in a glass bottle after 8 washing cycles was 
recorded. It is evident that in this case the oxidation occurred faster in the first case 
(Figure 5).  
Figure 5. Time course extinction spectra of GNRs synthesized in a glass bottle washed 8 times 
with milli-Q water after treatment with aqua regia. 
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In another experiment, aqua regia prepared one week before the synthesis was used for 
the treatment of the bottle. The extinction spectra of GNRs recorded during the 
synthesis are reported in Figure 6. As it can be clearly seen, the speed of the oxidation 
was definitely lower than for GNRs synthesized in the glass bottle treated with freshly 
prepared aqua regia. 
Figure 6. Extinction spectra of GNRs synthesized in a glass bottle treated with “old” aqua regia. 
!
In Figure 6 GNRs exhibit a blue-shift of the LSPR from 854 nm to 810 nm within 72h 
and then remain stable, indicating that the oxidation occurred only during the first three 
days. 
Subsequently, the effect of the lowering of the pH during the synthesis was tested. 
Therefore hydrochloric acid was added during the synthesis to obtain a growth solution 
at pH 1. The effect of the direct addition of HCl is illustrated in Figure 7. In these 
conditions the oxidation occurred faster respect to the synthesis performed without 
addition of HCl (pH 3). Results are consistent with the experiments reported in 
literature in which the direct addition of HCl combined with a high temperature (90°C) 
results in a consistent blue-shift of the LSPR and selective shortening of GNRs.[16] 
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Figure 7. Time course extinction spectra of GNRs synthesized at pH 1. 
!
A comparison with the selective shortening with FeCl3 
In literature several methods for the selective shortening of GNRs are reported. In order 
to compare GNRs synthesized in a pretreated glass bottle with those methods, a selective 
shortening of GNRs with FeCl3[12] was reproduced in the same laboratory.  
The oxidation was performed on GNRs with higher AR (see Figure S1) simply by 
addition of 5 mM FeCl3 in the GNRs solution. The oxidation was fast and the LSPR of 
GNRs showed a blue-shift of approximately 40 nm  in only 10 minutes.  
Figure 8. TEM images of GNRs before (A) and after (B) oxidation with 5mM FeCl3. Scale bars: 
100 nm 
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Thereafter GNRs were centrifugated, the supernatant removed and then resuspended in 
water to stop the oxidation. Figure 8 reports the TEM images of GNRs before and after 
the oxidation, while Figure 9 shows the extinction spectra of GNRs before and after 10 
minutes of oxidation as well as after the centrifugation. It is evident that the process 
cannot be interrupted immediately since the oxidation occurred even during the 
centrifugation as it can be seen in the extinction spectra in Figure 9. 
Figure 9. Extinction spectra of GNRs before and after oxidation with 5 mM FeCl3. !
Moreover, GNRs obtained though the oxidation with FeCl3 were bigger than GNRs 
obtained through the synthesis in a pretreated glass bottle. The difference in size of 
GNRs obtained through these methods is illustrated in the TEM images in Figure 10. 
Specifically, the size of GNRs obtained after etching with FeCl3 was 7x26nm.  
Figure 10. TEM images of GNRs after etching  with FeCl3 (A) compared to GNRs obtained after 
48h in the glass bottle (B). Scale bars: 100nm 
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3. Discussion !
The key term of the GNRs’ oxidation is the pretreatment with aqua regia (HCl:HNO3, 
3:1) of the glass bottle used for the synthesis. During this process hydronium ions (H3O+) 
exchange protons for the alkali ions leaching from the glass network.  
H3O+ + =Si−O− Na+ ➔ =Si−OH + H2O + Na+ 
This process results in a hydrated silica-rich surface layer, sometimes referred to as gel 
layer [15].  
Moreover, the combination of hydrochloric and nitric acids produces nitrosyl chloride 
(NOCl), according to the following reaction:[17] 
HNO3 + 3 HCl → Cl2 + 2 H2O + NOCl 
NOCl is a strong oxidizing agent and its adsorption on glass surfaces, and subsequent 
release by pumping, has been demonstrated by E. M. Stoddart [18]. Therefore, if the glass 
bottle treated with aqua regia is used immediately without any further treatment, the 
surface is saturated with NOCl which can be released during the GNR’s synthesis.  
Therefore the release of NOCl along with the presence of a considerable concentration 
of bromide in solution (from CTAB) can promote the selective shortening of GNRs 
through oxidation of Au into the colorless AuBr2−, but not into the yellow AuBr43−. 
Table S1 reports the standard reduction potentials of the half reactions involved in the 
oxidation process. 
It is well-known that GNRs of AR 2-5, prepared in the presence of surfactants (i.e. 
CTAB) have unstable {110} facets [18]. Moreover, due to the presence of CTAB, which 
adsorbs preferentially on {100} facets, both growth and shortening reactions occur mainly 
at the ends of single-crystalline GNRs.[12]  
Therefore, thanks to the presence of NOCl released from the glass bottle, the oxidation 
of GNRs occurred mainly at the ends of the rod leading to a shortening of the nanorods. 
These results are in agreement with a previous work by Stucky et al. [14] . However, in 
this latter case the oxidation occurred only at the ends of the rods, while in the present 
work it is evident that the oxidation occurred also on the surface along the rods. 
Moreover, in this synthesis an increase of the temperature was not to necessary to speed 
up the oxidation and the process could be interrupted simply removing the solution 
from the glass bottle and store GNRs in a plastic container.  
!42
Chapter 1                                                                     Synthesis of Small Gold Nanorods with Tunable Aspect Ratio
The speed of the oxidation can be controlled by varying the number of washings with 
milli-Q water after treatment with aqua regia or lowering the pH by addition of HCl. In 
fact, if the glass bottle was washed 8 times the oxidation process was faster than the same 
synthesis performed after 10 washings, presumably due to the higher amount of NOCl 
that can be released. In the other case, the addition of HCl enhances the oxidation rate 
of GNRs because the addition of H+ increases the reduction potential of the half-
reaction of O2, which can also be involved [14] . In fact, in this latter experiment the 
oxidation could be interrupted only through centrifugation and washing. [14] 
A proof of the effect of NOCl adsorption on the glass wall of the bottle is the 
experiment performed after treatment with “old” aqua regia. In this case the oxidation 
was slow and after 72h further shortening was not detected, indicating that all the NOCl 
was already released. In fact, in nitric acid NOCl is readily oxidized into nitrogen 
dioxide; therefore, presumably, when“old” aqua regia is used for the treatment less 
NOCl can be adsorbed on the glass surface, reducing its oxidizing effect on GNRs.  
4. Conclusions 
In the present chapter a method to synthesize GNRs with a size smaller than those 
obtained with the seeded-growth method is illustrated. This novel method consists of an 
in-situ oxidation of GNRs directly during the synthesis through pretreatment of the glass 
bottle used for the synthesis. The NOCl release-mediated oxidation of GNRs can be 
interrupted simply removing the solution from the treated glass container, allowing a 
good control of the AR and the LSPR of GNRs. Therefore the problem of a continuos 
oxidation during the centrifugation and washing, which is necessary to stop the 
oxidation in common shortening process [14],  can be avoided. Moreover, contrary to the 
seedles method [11], the present synthesis can be scaled up and considerable amount of 
GNRs can be synthesized. In a future work this system could be engineered for the 
production of GNRs in continuos through the use of a reservoir of GNRs and pumping 
nanorods in a treated glass tube. Therefore, the control of GNRs’ flow into the glass tube 
could provide GNRs with different length in a large scale. 
!
!
!
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5. Experimental section 
Materials 
Sodium borohydride (>98%), cetyltrimethylammonium bromide (>99%), and silver 
nitrate (99.5%) were purchased from Acros Organics. Chloroauric acid (99.9%) was 
purchased from Strem Chemical, and L-(+)-ascorbic acid was purchased from Alfa Aesar, 
while polysorbate 20 (Tween20) was obtained from Sigma Aldrich. All chemicals were 
used as received. All the solutions were prepared with deionized water produced by a 
Millipore System. !
GNR synthesis 
GNRs’ synthesis was performed in a 250 ml glass bottle. Before synthesis the bottle was 
filled with approximately 100 ml of freshly prepared aqua regia (HCl:HNO3, 3:1) and 
gently shaked. Thereafter, aqua regia was left in the bottle overnight and then removed. 
After the cleaning with aqua regia, the bottle and the magnetic stir bars were thoroughly 
washed (8-10 times) with 100 ml of Milli-Q water and immediately used for the synthesis 
of GNRs with tunable length.  For the synthesis of GNRs with AR of 4.9, the glass bottle 
was left overnight in milli-Q water and dried before use. GNRs were synthesized by a 
seed-mediated method according to Nikoobakht et al. [3]  and Ratto et al.[6]  modified as 
follows.  !
1) Preparation of the seeds       
CTAB (218.5 mg) was added in a 20 ml glass vial with a small stir bar. Then 6 ml of milli-
Q water were added and CTAB was dissolved by heating at 37°C and gently stirring the 
solution with a stirring/hot plate, to obtain a solution of 0.1 M CTAB. HAuCl4 0.01M 
(144 μl) was added and the solution was gently stirred. The vial was covered with 
aluminium foil and the speed of the stirring was increased. Thereafter, NaBH4 0.015 M 
(229.5 μl) was quickly added and the solution was stirred for 10 minutes. After the 
addition of NaBH4 the solution changed color, from orange to yellow brownish, 
indicating the formation of gold seeds. Then the stirring was stopped and the seeds 
solution was left undisturbed in the dark for 1 hour and 50 minutes. !!!
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2) GNRs’ growth       
CTAB (4.05 g) was added in a 250 ml glass bottle with 100 ml of milli-Q water and a big 
stirring bar. The solution was heated at 37°C and gently stirred to allow the dissolution 
of CTAB. Then HAuCl4 0.1M (470 μl) was added and the solution was stirred for a 
while. Subsequently, AgNO3 0.1 M (92 μl for GNRs with AR 4.8 and GNRs with 
tunable length obtained with the oxidation; 48 μl for GNRs AR of 3.9 ± 0.8, with a 
width of 7.5 ± 1.0 nm and length of 28.6 ± 3.5 nm (LSPR at 789 nm)was added and the 
solution was gently stirred. AA 0.01 M (4.5 ml) was added drop-wise with a burette to the 
solution continuously stirred. During the addition of AA the solution changed color, 
from orange to colorless, indicating that Au(III) was reduced to Au(I). Thereafter the 
15% more AA (0.675 ml) and Tween 20 10% (1 ml) were added and the solution was 
gently stirred. The glass bottle was covered with aluminium foil and the speed of the 
stirring increased before seeds addition. Finally, 1.8 ml of the seeds solution was quickly 
added to the growth solution and stirred for 30 minutes. The color of the growth 
solution turned to brown, indicating the formation of gold nanorods. 
Then GNRs where stored as follows, depending on the type of synthesis performed.  !
A) Synthesis of GNRs with tunable length: after 30 minutes the stirring was stopped       
and the GNRs’ oxidation started. When the desired AR was obtained, the reaction was 
stopped removing the growth solution from the glass bottle and stored in plastic 
containers and stored in the dark at room temperature. !
B) Synthesis of GNRs with AR 4.8: after 30 minutes from seeds injection the GNRs’       
solution was simply stored in the dark at room temperature. !
All the GNRs were then washed as reported in Chapter 1. !
GNRs characterization 
After the synthesis, the structural and optical properties of GNRs were characterized by 
Transmission Electron Microscopy (TEM) and spectrophotometric analysis. TEM images 
were acquired on a JEOL 200FX with a tungsten filament operating at 200 kV. Optical 
extinction spectra were recorded using a Molecular Devices SpectraMax M2 plate reader. !
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UV-vis-NIR 
After the synthesis 700 μl of the growth solution was put into a disposable plastic cuvette 
and the spectrum of GNRs was recorded between 400 nm and 1000 nm with a step of 2 
nm. A solution of CTAB 0.1 M (700 μl) was used as a reference for the measurement. !
TEM 
A TEM sample was prepared as follow: a small amount of the growth solution (1.5 ml) 
was washed as reported in Chapter 1. After washing 10 μl of the GNRs solution was 
carefully deposited with a pipet on the TEM grid, the sample was then covered and 
stored overnight to allow a slow drying of the drop on the TEM grid. The sample was 
analyzed with the transmission electron microscope. !
Determination of the size 
The size of the GNRs was estimated as follow: the sizes of 300 GNRs were measured 
with ImageJ software and the average width, length and AR were calculated. !!!!!!!!!!!!!!!!!!!
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6. Supporting Informations 
 
Figure S1. TEM images of GNRs collected after 48h (A) and 72h (B) from a 500 ml batch. Scale 
barr: 100nm. 
!!!!!!!!!!!!!!!!!
Figure S2. Normalized extinction spectra of GNRs collected during the synthesis of 500 ml 
batch. !
!47
Chapter 1                                                                     Synthesis of Small Gold Nanorods with Tunable Aspect Ratio
Table S1. Standard reduction potentials of some related half reactions 
!
From “Electrochemical Series”, in CRC Handbook of Chemistry and Physics, Internet Version 
2005; Lide, D. R., Ed.; <http://www.hbcpnetbase.com>; CRC Press: Boca Raton, FL, 2005. 
*The reduction potential  of NO+ to NO has been measured in non aqueous media and 
estimated for water [20]. !!
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Rapid Purification of Small Gold Nanorods* !
* F. Scaletti, C. S. Kim, L. Messori, V. M. Rotello, Rapid Purification of Gold Nanorods 
for Biomedical Applications. MethodsX 1 (2014) 118-123. !
Graphical abstract 
!
!
1. Introduction 
Among the various gold NPs, gold nanorods (GNRs) have attracted particular attention 
due to their unique properties (structural, optical, and electronic) [1,2]. Moreover, facile 
and well-established synthetic routes (e.g., seed-mediated growth protocol [3]) permit to 
produce stable structures of GNRs with high yield and monodispersity. 
However, the common synthetic method of GNRs, such as the seed-mediated method 
[3], produces a variety of gold spheres and cubes as by-products. Several methods such as 
selective precipitation [4,5] or oxidation [6], size exclusion chromatography [7], 
electrophoresis [8], and centrifugation [9,10], have been reported for the purification of 
high AR (AR > 4), relatively big sized GNRs (width ≥ 10 nm). Moreover, it is difficult to 
separate small sized GNRs while there is an increasing demand of small GNRs because 
of their strong absorption properties [11] and their high-payload-to-carrier ratio (e.g., 
drug delivery) [12]. Here, a method for the separation of small GNRs has been 
optimized. This method does not require the addition of surfactant or salts. Moreover, a 
large amount of GNRs can be easily obtained from by-products with a high yield. 
!
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2. Results and Discussion !
Method of purification 
The final reaction mixture for GNRs contains the desired GNRs, a variety of gold 
nanoparticles (NPs) of different shapes (spherical, cubic, etc.). To obtain a homogeneous 
population of GNRs, two cycles of centrifugation were carried out. After the synthesis, 
all reaction products (spheres, cubes, and rods) were first isolated and purified from the 
excess of cetyltrimethylammonium bromide (CTAB) through centrifugation at high rpm. 
CTAB needs to be removed as much as possible for many applications owing to its 
cytotoxicity [13]. Then, shape separation was afforded through a second cycle of 
centrifugation adapted from the method reported by Sharma et al. [9] and optimized for 
the size of interest. 
Due to the large shape-dependent differences in the respective sedimentation velocities, 
in the course of centrifugation, spheres and cubes were sedimented at the bottom of the 
centrifuge tube while most GNRs remained in the supernatant solution. Therefore, an 
efficient shape separation can be achieved by tuning the centrifugation times and speeds 
(see Materials and Methods section).  
In order to choose the best conditions of separation, different time and the speed of 
centrifugation have been tested as reported in SI section. 
Characterization of purified GNRs 
After separation, the colors of the solutions of the three samples were clearly different as 
shown in Fig. 1. In fact before separation the solution of reaction products was reddish 
brown (Sample A) and after the second cycle of centrifugation the solutions of purified 
GNRs and by-products were brown (Sample B) and red (Sample C), respectively. 
Figure 1. Separation of gold nanorods from reaction products. The figure shows the reaction 
products after the first centrifugation (A), the supernatant after the shape separation (B), and the 
resuspended precipitate (C). 
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Moreover, the structural and optical properties of the separated NPs (Samples B and C) 
were characterized by optical extinction spectra and TEM images, compared to Sample A 
(Figures 2 and 3). The absorption spectrum relative to Sample A (Figure 2) showed a 
transversal surface plasmon peak with a maximum at 514 nm and a broadening at longer 
wavelength, indicating the presence of GNRs and spherical and cubical NPs as well. The 
absorption spectrum of Sample C showed that, after the separation, the maximum of the 
surface plasmon peak was at 522 nm while the spectrum relative to Sample B showed a 
transversal surface plasmon peak with a maximum at 510 nm. These differences 
indicated the loss of spherical and cubical NPs in Sample B while the bulk of the by-
products were in Sample C. Moreover, the longitudinal surface plasmon peak with a 
maximum at 800 nm in the absorption spectra of Sample C indicated that some GNRs 
were present as well.  
!
Figure 2. Absorption spectra of reaction products after the first centrifugation (A), the 
supernatant after the shape separation (B), and the resuspended precipitate (C). !
The size and shape of the reaction products (Sample A) and separated NPs (Sample B 
and Sample C) are shown in the TEM images (Figure 3). As a result, Sample B (Figure 
3B) was comprised mainly of GNRs while Sample C (Figure 3C) contained mostly 
spherical NPs, confirming the shape separation by the two steps of centrifugation. !!
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Figure 3. TEM images of reaction products after the first centrifugation (A), the supernatant after 
the shape separation (B), and the resuspended precipitate (C). Scale bar:  100 nm. 
!
Quantification of the separation 
The quantification of the separation was evaluated in terms of volume percentage of by-
products (spheres and cubes) or GNRs respect to the total volume of all the reaction 
products (Figure 4).  
Figure 4. Volume percentage of by-products (spheres and cubes) and GNRs in the sample after 
the first centrifugation (A), in the supernatant after the shape separation (B), and in the 
resuspended precipitates (C). !
Before separation, Sample A was comprised of 41.5% of by-products and 58.5% of 
GNRs (Figure 4A). After separation, Sample B contained 79.4% of GNRs and 20.6% of 
by-products while Sample C consisted 14.2% of GNRs and 85.8% of by-products. As 
shown in Figure 1, it is important to notice that the sizes (and the volumes) of most by-
products were larger than the size of GNRs, implying that even a small amount of by-
products greatly affect the total volume of the sample. 
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3. Conclusions 
In the present Chapter a modified method for the purification of small GNRs from 
reaction by-products (i.e. spherical and cubic nanoparticles or aggregates) is accurately 
described. Contrary to other methods, the present one does not require the addition of 
surfactant or salts and large amount of GNRs can be easily separated from by-products 
with a high yield. 
 
4. Experimental section 
Materials 
Sodium borohydride (>98%), cetyltrimethylammonium bromide (>99%), and silver 
nitrate (99.5%) were purchased from Acros Organics. Chloroauric acid (99.9%) was 
purchased from Strem Chemical, and L-(+)-ascorbic acid was purchased from Alfa Aesar. 
All chemicals were used as received. All the solutions were prepared with deionized water 
produced by a Millipore System. !
GNR synthesis 
GNRs, with AR of 3.9 ± 0.5 (width= 7.5 ± 0.8 nm, length= 28.6 ± 3.5 nm) were 
synthesized by a seed-mediated method according to Nikoobakht et al. [14] and Ratto et 
al. [15] modified according to the synthetic procedure reported in Chapter 1. After the 
synthesis, the structural and optical properties of GNRs were characterized by 
Transmission Electron Microscopy (TEM) and spectrophotometric analysis. TEM images 
were acquired on a JEOL 200FX with a tungsten filament operating at 200 kV. Optical 
extinction spectra were recorded using a Molecular Devices SpectraMax M2 plate reader. !
Method 
The GNRs were separated from excess CTAB and then purified from the by-products 
through centrifugation with an Eppendorf centrifuge 5810R using 2 ml centrifuge tubes. 
During centrifugation, temperature was kept at 27°C to avoid the crystallization of 
CTAB that may affect the separation. !
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Step 1: GNR separation from CTAB  
The purification from excess of CTAB and unreacted Au(I) as follow: 
- Synthesized GNRs were placed in centrifuge tubes (1.5 ml of GNRs for each 
centrifuge tube) and centrifuged at the rate of 10630 rpm (12000 × g) for 30 min. After 
centrifugation, precipitates can be clearly seen at the bottom of the centrifuge  tubes. 
- The supernatant was carefully removed with a pipet, leaving a volume of ∼50 μl 
solution with the 
precipitates. 
- The precipitates were resuspended by addition of 1.45 ml of Milli-Q water, 
leading to a final volume of 1.5 ml. 
- The resuspended GNRs were then combined (Sample   A). !
Step 2: Shape separation 
- The isolated products from the first centrifugation were placed in centrifuge 
tubes (1.5 ml for each centrifuge tube) and centrifuged at the rate of 6000 rpm (3824 g) 
for 15 min. 
- The supernatant (GNRs) was carefully collected with a pipet (Sample B), leaving 
∼50 ml of    the solution with the precipitates in the centrifuge tubes. 
- The precipitates at the bottom (spheres and cubes) in the 50 ml of the solution 
were resuspended by the addition of 1.45 ml of Milli-Q water, leading to a final volume 
of 1.5 ml. 
- All the resuspended GNRs were then combined (Sample    C). !
Step 3: Quantification of the separation 
The quantification of the separation was estimated as follow: 
- The sizes of 300 NPs (spheres, cubes and GNRs) for each sample were measured 
with ImageJ software: spherical NPs showed the average diameter of 28.6 ± 4.7 nm, 
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cubes showed the average side length of 14.1 ± 2.9 nm while GNRs showed a width of 
7.5 ± 0.8 nm and length of 28.6 ± 3.5 nm. 
- The volumes of spherical, cubical NPs and GNRs were calculated; to calculate 
the volume of GNR, the shape of GNR was approximated to a cylinder capped with two 
half-spheres. 
- The quantification of the separation was expressed in terms of volume 
percentage of by-products (spheres and cubes) or GNRs respect to the total volume of all 
the reaction products (Figure 4). !
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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5. Supporting Informations 
The following is an other example of separation of a GNRs’ batch with a high amount of 
spherical by-products. 
Figure S1. An other example of absorption spectra of reaction products after the first 
centrifugation (black line), the supernatant after the shape separation (blue line), and the 
resuspended precipitate (red line). 
Figure S2. TEM images of reaction products after the first centrifugation (A), the supernatant 
after the shape separation (B), and the resuspended precipitate (C). 
!
!
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In order to choose the best conditions of separation, different time and the speed of 
centrifugation have been tested as reported below. 
!
Figure S3. Absorption spectra of GNRs purified through a first centrifugation at 10630 rpm 
(black line) and a second one at 6000rpm for 5 minutes.  
   !!
Figure S4. Absorption spectra of GNRs purified through a first centrifugation at 10630 rpm 
(black line) and a second one at 5000rpm for 15 minutes.  
!
!
!
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Figure S5. Absorption spectra of GNRs without the first centrifugation at 10630 rpm (black line) 
and purified only with a centrifugation at 6000rpm for 15 minutes. 
 
Figure S6. Absorption spectra of GNRs without the first centrifugation at 10630 rpm (black line) 
and purified only with a centrifugation at 5000rpm for 15 minutes. 
!
!
!
!
!
!
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Figure S7. Absorption spectra of GNRs without the first centrifugation at 10630 rpm (black line) 
and purified only with a centrifugation at 6000rpm for 5 minutes. 
!
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1. Introduction 
The cellular applications of plasmonic particles in the context   of biomedical optics, 
ranging from imaging and diagnostics to therapeutics, have received considerable 
attention over recent years[1-5]. With actual perspectives to reach the clinical arena, the 
need for well-characterized and biocompatible particles is becoming urgent. However, in 
spite of an increasing number of studies, the available data in the scientific literature 
remain fragmented and heterogeneous.[6,7] Among the various plasmonic particles, so-
called gold nanorods (GNRs) are attracting particular interest because of their unique 
optical  properties [8], extreme  efficiency  and stability of photothermal conversion [9] 
and biochemical versatility. Their optical absorbance exhibits two intense resonances 
that correspond to orthogonal modes of plasmonic oscillations, i.e. a transversal mode in 
the green region and a longitudinal mode in a range of frequencies that may be tuned in 
the far red-near infrared window (650-1000 nm) of principal interest in biomedical optics 
[8].  
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The wavelength of this resonance depends on the particle shape and in particular the 
aspect ratio (i.e. length divided by diameter, AR), with the particle size playing a 
secondary role [10,11]. Other factors  of  impact  on  the  frequency  of  both  transversal 
and longitudinal bands are the refractive index of the environment and particle 
aggregation. [12] All these features make GNRs ideal contrast agents and sensitizers for 
applications such as the photoacoustic imaging [13] and the optical hyperthermia of 
cancer. [14] 
Crucial features of GNRs include their coating, shape and size. The kind of coating is 
critical to modulate their interface with the biological  systems,  enable to  bind 
functional  moieties  such as ligands and govern the colloidal stability in culture media 
and body fluids. Polyethylene glycol (PEG) is perceived as the coating  of  choice  because 
of its biocompatibility, [15-17]  ability to avoid the detection from macrophages, readiness 
of biochemical modification and steric hindrance against particle aggregation.  
As it was mentioned, the choice of particle shape follows from the need for specific 
spectral features. Therefore, particle size remains the principal variable to play with. 
Particle size may modulate critical parameters such as: the cellular penetration, [18,19] 
the intracellular localization, [20] the biodistribution, [21] features that depend on 
specific surface area, including the rate of interaction with proteins, residual toxicity of 
contaminants or load of ligands, [20]  the ratio of optical absorption to scattering, [11] 
the efficiency and stability of photothermal conversion and the optical and thermal 
hotspot distribution. [22] As mentioned above, for individual GNRs, the light extinction 
cross sections roughly scale with the particle volumes. [9,11] Therefore, in order  to 
maintain   the  same  optical  absorbance, one should compare samples containing the 
same gold molarity, rather than e.g. the same particle density by number.  
In the present chapter, an extensive survey on the characterization, stability, toxicity and 
cellular uptake of PEGylated GNRs (PEG-GNRs) of five different size classes is 
presented. 
A critical  requirement for biomedical applications of GNRs is their colloidal stability in 
physiological buffers. Previous studies showed that gold nanoparticles exposed to 
biological fluids may become coated with proteins, [23,24] which may modify their 
conformation, thus causing a loss of their biological activity, [25] elicit an altered 
immune response and modulate their biodistribution and cellular uptake.   
Here, the effect of particle size on the stability of PEG-GNRs in biological buffers and 
their interactions with significant proteins, such as the hen egg white lysozyme (HEWL), 
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cytochrome c (cyt c) and bovine serum albumin (BSA) has been addressed. The 
correlation between size and toxicity of gold nanoparticles of various shapes has been 
investigated in a few cases with alternate results. [16,21,26-30]      
While as-synthesized cetyltrimethylammoium (CTAB)-stabilized GNRs impart significant 
cellular damage, PEG-GNRs display little cytotoxicity. [17,31,32] This cytotoxicity may 
persist from the retention of contaminants used in the synthesis, such as CTAB and 
silver  ions,  which  may explain the correlation between particle surface area and cellular 
damage [16,33] and project a stronger toxicity for smaller particles. [21,27,34] To my 
knowledge, the effect of size on the cytotoxicity and cellular uptake of PEG-GNRs has 
never been reported before, which requires a careful examination of multiple parameters 
including cell proliferation, viability, membrane integrity and blood compatibility. 
Moreover, in order to avoid a possible bias that may affect existing data [7] due to the use 
of HeLa cells with their anomalous phenotype, we resort to a battery of cellular models. 
Finally, the size of PEG-GNRs may affect their cellular uptake by nonspecific 
interactions, which is another critical issue in view of biomedical applications. Although 
the available literature is inconclusive, [6] particle size was found to modulate their 
cellular uptake and determine different mechanisms of internalization. [6,23] In this 
chapter, all these  issues are scanned in a range of particle concentrations of common use 
in preclinical trials for therapeutic applications in rodents, i.e. in the order of 10 mg Au/
Kg tissue, or 50 µM Au. [35-38] 
2. Results 
Size and shape of gold nanorods 
In order to be as representative as possible, PEG-GNRs were prepared by usual protocols 
with slight modifications to tune their size statistics. In particular, GNRs were 
synthesized by the common seed-mediated approach, [39,40] where particle growth is 
triggered by the injection of gold nuclei in a growth solution and develops without 
additional nucleation. [39,41] The initial seed density  equals the final particle density 
and so dictates the average particle size, because the ions in the growth solution are 
shared in either of a larger number of smaller particles or a smaller number of larger 
particles. Instead the typical particle AR exhibits little dependence on the initial seed 
density. Here, these notions were exploited to modulate the average particle size at 
comparable shape statistics. 
!69
Chapter 3                                                                Size Dependent Biological Profiles of PEGylated Gold Nanorods
Figure 1 displays a spectroscopic and microscopic analysis of five different size of GNRs.  
Figure 1. Light extinction spectra, representative (170 × 100) nm2 TEM micrographs, volumetric 
distributions of particle aspect ratios and volumes of samples GNRs 1/9, 1/3, 1, 3 and 9 from top 
to bottom. 
From sample to sample, the experimental spectra are consistent in terms of peak 
intensities and positions, which reflect their sameness of gold molarity [22,41,42] and 
typical particle shapes, respectively. The transmission electron micrographs corroborate 
our predictions on the trends of particle volumes and  AR  with  the seed  density. The 
volumetric distributions of particle AR are consistent from sample to sample, despite 
subtle modifications of particle shapes, such as lesser quasi spherical byproducts and 
more dogbone profiles [39,43] at lower seed densities. Instead, typical particle volumes 
scale well with the inverse of the seed density. The average particle effective radii are 
(19.4 ± 0.4), (13.5 ± 0.3), (9.8 ± 0.2), (6.8 ± 0.4) or (4.8 ± 0.5) nm. We note that the 
overlap between the volumetric distributions of particle volumes of every second sample 
is rather negligible.  
After synthesis, GNRs were PEGylated by standard methods for gold nanoparticles and 
substrates. [44] By the use of dynamic light scattering, we found that the hydrodynamic 
thickness of the PEG shells in PBS was about 13-18 nm for all samples, which suggests a 
so-called brush [45] configuration and a density in the order of 0.8 PEG strands per nm. 
Purification from contaminants was pursued by extraction in a common surfactant such 
as polysorbate 20 and five cycles of centrifugation and decantation. Additional details on 
sample preparation are given in the Experimental section. This variety of particle sizes 
covers the range of principal interest for biomedical applications, smaller particles 
beginning to display poor plasmonic oscillations [46] and larger particles becoming 
problematic for blood circulation.[47]  
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Hereafter, GNR’s samples will be labelled with the numbers 9, 3, 1, 1/3, 1/9, which 
indicate their relative average particle volumes with respect to sample 1. The latter 
corresponds to a standard size of ∼ 41 nm average length per ∼ 10 nm average diameter. !
Stability of PEGylated gold nanorods 
PEG-GNRs proved to be stable in the most common buffers for cell biology and in the 
presence of representative proteins.  In order to understand the stability of PEG-GNRs 
in the presence of representative biological components, we monitored possible 
variations of their plasmonic bands at ∼520 and ∼780 nm, which display high sensitivity 
to particle aggregation,[12] protein adsorption [48] and charge injection.[49,50].  
Therefore, the stability of the various PEG-GNRs in the presence of relatively large 
concentrations of representative proteins in PBS was tested. Experiments were 
performed at 37°C, in an attempt to represent physiological conditions. Three different 
proteins were chosen for these tests, namely BSA (Figure 2), HEWL and cyt c (Figures S1 
and S2 of the SI section). The choice of these proteins was guided by their importance, 
globular structure, stability, solubility and availability. Their addition up to a final 
concentration of 10 µM did not significantly affect the plasmonic bands of all PEG-
GNRs. Only minor shifts were noticed around 780  nm  in  a  few  cases.   
Figure 2. Light extinction spectra of PEG-GNRs of different average size in PBS containing BSA 
A) GNRs 1/9; B) 1/3; C) 1; D) 3; E) 9. The figure shows spectra recorded at time zero (black line) 
and after 1 h (green line), 24 h (red line) and 168 h (blue line). 
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The  onset  of  partial  flocculation and sedimentation  led to  a modest  decrease in 
optical density over one week. The case of cyt c is particularly informative, as this protein 
exhibits an intense Soret band around 400 nm, arising from its heme cofactor. This 
feature allowed us to simultaneously monitor both the protein and the particles. No 
significant changes were observed right after mixing nor after two days, which implies a 
substantial weakness of possible interactions. However, after one week of incubation a 
partial reduction of cyt c was noticed as it can be seen from the appearance of the typical 
spectrum of the cyt c’s reduced form. [51] It is known that the cyt c in solution may reach 
an equilibrium between the oxidized and reduced form.[52] Therefore, the subsequent 
blue-shift of the GNRs’ longitudinal band may be ascribed to the charge injection due to 
cyt c reduction. Direct evidence of this weakness comes from the possibility to readily 
separate these species by centrifugation. The residual amount of cyt c adsorbed on PEG-
GNRs turned out to be negligible, as it  is shown in Figure S3 of the SI section.  
The effects of addition of RPMI medium (Figure 3) was also analyzed. For all PEG-
GNRs, a significant and progressive red-shifts of the main bands at 780 nm occurred. 
This process is relatively  slow and reaches completion in a few days. In agreement with 
previous reports, red-shifts imply changes in the local environment of the PEG-GNRs.
[49,50] It is hypotesized that this effect may follow from the interplay of partial PEG 
substitution and selective adsorption of different components in a complex environment 
such as RPMI. [52] Notably, the spectra of PEG-GNRs with BSA differ much from those 
in RPMI. Therefore, BSA alone cannot be responsible for the modifications seen in 
RPMI. [26] 
!
!
!
!
!
!
!
Figure 3. Stability of PEGylated gold nanorods in RPMI. Light extinction spectra of PEG-GNRs 
of different average size in RPMI A) GNRs 1/9; B) 1/3; C) 1; D) 3; E) 9. The figure shows spectra 
recorded at time zero (black line) and after 24h (green line), 72h (red line) and 168h (blue line). 
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Cytotoxicity and cell viability 
PEG-GNRs did not significantly affect the cell viability and were not cytotoxic, with the 
exception of the smallest size class. In order to evaluate the cytotoxic effects of PEG-
GNRs, we combined two quantitative colorimetric assays indicating both survival/
growth and viability of cultured cells. The inhibition of cell growth was assessed by the 
SRB test, which measures the total amount of proteins, and therefore the presence of 
cells, in  the microtiter plates. Cell viability was analyzed by the MTT test, which 
quantifies the reduction of tetrazolium salts by metabolically active cells. MTT is the test 
of choice in many studies  on  particle  toxicity, thus enabling a direct comparison with 
the available  literature.[33] Furthermore, the effect of an acute treatment with PEG-
GNRs on cell membrane integrity was evaluated. The combination of different tests is 
important because the biological activity of gold nanoparticles and its mechanisms of 
action remain  largely unknown and the output of each individual test may be biased by 
the interference with the particles. 
Table 1 Inhibitory effect of 5 different suspensions of PEG-GNRs on cell growth of HeLa, 
A2780/S, SKOV3 and IGROV-1 cell lines after 72 and 168 h exposure. 
a IC50 is defined as the concentration of drug required to inhibit cell growth by 50%; SD, 
standard deviation; data represent the mean of three independent experiments each performed in 
triplicate. !
• Cell growth inhibition.  
The cytotoxic effects of PEG-GNRs were evaluated against four tumor cell lines 
(HeLa, A2780/S, SKOV3 and IGROV-1) after 72 and 168 hours exposure (Table 1 
and Figure 4). After 72 hours, 50% inhibitory cell growth thresholds (IC50) were not 
reached at gold concentrations up to 100 µM. However, at the highest concentration 
(100 µM Au), some inhibition was observed. Such an effect varied among the 
different cell lines: lower in HeLa cells  (range  2.5-7.9%) and higher in IGROV-1 cells 
(range 35.9-46.3%), but without a clear pattern to particle size.  
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Figure 4. Cytotoxic effects of 5 different suspensions of PEG-GNRs on cell growth of HeLa, 
A2780/S, SKOV3 and IGROV-1 cell lines after 72 h (panels A, C, E, G) and 168 h (panels B, D, 
F, H) exposure. The figure shows values for GNRs 9 (●), 3 (■), 1 (▲), 1/3 (▼), 1/9 (♦). !
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• After 168 h exposure, the IC50 threshold was not reached in HeLa and A2780/S 
cells. In    this case, at 100 µM Au, the inhibitory growth effects on HeLa and A2780/
S cells ranged from 1.8 to 15.8% and from 17.7 to 29.3%, respectively with irrelevant 
dependence on particle size.  
A similar behaviour was also observed in SKOV3 cells treated with larger GNRs 9, 3 
and 1: although IC50 values were not reached, the inhibitory effect at 100 µM Au 
was 29.4, 22.5 and 39.5% respectively. Conversely, smaller GNRs 1/3 and 1/9 gave 
IC50 values of   77.5 and 53.7 µM Au, respectively, indicating that in this cell line the 
cytotoxicity of PEG-GNRs seems to grow with miniaturization.  
All PEG-GNRs exhibited IC50 thresholds ranging from 10.3 µM to 41.0 µM Au 
against IGROV-1 cells with poor dependence on particle size. 
• Cell viability.  
The effects of PEG-GNRs on cell viability were evaluated against four tumor cell 
lines (HeLa, A2780/S, SKOV3 and IGROV-1) after 24 hours exposure (Figure 5). All 
PEG-GNRs did not affect HeLa cells up to 100 µM Au and exhibited a moderate 
inhibition of cell viability only at 300 µM Au, which did not vary with particle size. 
!
Figure 5. MTT test on HeLa, A2780/S, SKOV3 and IGROV-1 cell lines after 24 h exposure 
to PEG-GNRs. Cell viability is expressed as percent of MTT reduction in treated cells with 
respect to control cells. Reported data represents the mean ± standard deviation of three 
independent experiments. Figure shows values for GNRs 9 (●), 3 (■), 1 (▲), 1/3 (▼), 1/9 
(♦). !
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A2780/s and IGROV-1 cells suffered from moderate inhibition of cell viability with 
all particle sizes, but this effect started at lower concentrations (10 µM Au) for 
smaller GNRs 1/9 with respect to the others  (30-100 µM  Au). 
The same trend was  observed for SKOV3 cells. Although a different sensitivity of 
the various cell lines was observed, with HeLa cells holding the greatest resistance, 
the principal trends with particle size did not depend on cell line. Smaller particles 
provided slightly more MTT reduction inhibition,  which  falls  below  statistical 
relevance and emerged only at high gold concentrations.  !
• Membrane integrity.  
Membrane stability after exposure to PEG-GNRs was assessed by fluorescence 
analysis of calcein efflux. Calcein-AM is a non fluorescent dye that permeates cell 
membranes. In live cells, intracellular esterase converts calcein-AM to green 
fluorescent calcein, which is unable to pass intact cell membranes. In the case of 
membrane integrity disruption, which may reflect multiple conditions of cell damage, 
a decrease in intracellular calcein fluorescence would be observed.[54] Figure 6 shows 
fluorescence  images  of  A2780/s  cells  preloaded with calcein-AM  and treated with 
PEG-GNRs. After 3 h exposure at 300 µM Au, none of the particles induced leakage 
of calcein, thus indicating the absence of membrane permeabilization. All cell lines 
gave similar results (Figure S4 of the SI section). 
!
Figure 6. Calcein fluorescence in untreated A2780/S cells and after treatment with PEG-GNRs 
of different average size. 
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Blood compatibility and cellular uptake 
PEG-GNRs proved to be safe for intravenous injection, without haemolytic activity nor 
significant detection from immune cells, especially for smaller sizes. The potential of 
PEG-GNRs for biomedical applications depends on their compatibility with a systemic 
administration. In addition, their unspecific cellular uptake may impair their potential to 
reach specific targets such as tumors. The effect of particle size on the haemolysis and 
unspecific uptake by HeLa cells taken as a standard model (Table 2) has been analyzed. 
Moreover, the results obtained with HeLa cells were compared with a monocyte/
macrophagic cell line (J774a.1), so as to distinguish the contribution  of specific 
macrophage functions. 
Table 2. PEG-GNRs uptake by HeLa and J774a.1 cells after different incubation times. Data are 
referred to the same number of cells. 
As indicated in Figure 7, none of the particles showed haemolytic activity, even at the 
highest concentrations. Data are referred to positive controls obtained by dosing 
ultrapure water to induce complete haemolysis. The effect of size on the cellular uptake 
of PEG-GNRs was investigated for three size classes with negligible statistical overlap (i.e. 
samples 1/9, 1 and 9, see Figure 1). The amount of gold internalized by HeLa cells 
exposed to 100 µM Au was evaluated at different time points. As shown in Table 2, there 
occurs little uptake in all samples, as it is expected for PEGylated particles and in 
particular GNRs. [20]  As a rule of thumb, uptake grows with particle size. Table 2 also 
reports the values obtained with J774a.1 cells after 24 hours of incubation and shows 
that both smaller and bigger PEG-GNRs are internalized to a bigger extent than those of 
an intermediate size. !!
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Figure 8. Left: red blood cells haemolysis from PEG-GNRs of different average size: data 
represent a mean of two independent experiments, both performed in triplicate, and haemolysis 
values are expressed as percentage of positive control. Right: representative transmission electron 
micrograph displaying a J774a.1 cell cultured on a transwell membrane and treated with PEG-
GNRs 1. !
The impact of PEG-GNRs on macrophages was also addressed by the analysis of TEM 
images of J774a.1 cells treated with sample 1 and prepared with a method that is most 
representative of the living structure. In Figure 8, the cell morphology clearly shows the 
absence of alterations. No particles were detected  within the cell nucleus or cytoplasm 
but in sporadic endocytic vesicles, indicating the rarity of unspecific internalization. 
!
!
!
!
!
!
!
!
!
!
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3. Discussion 
In  this  article,  different size classes of PEG-GNRs, which fall in a range suitable for 
biomedical applications of principal interest such as photoacoustic imaging and optical 
hyperthermia of cancer, different size classes. All PEG-GNRs are stable in PBS and their 
size does not modulate their interaction with proteins, which is very weak as it is seen in 
the case of cyt c. The data obtained with BSA are of particular relevance when 
considering PEG-GNRs for intravenous injection, albumin being the most abundant 
protein in the plasma. Conversely, the cell medium RPMI causes a significant red-shift of 
the plasmonic bands of all PEG-GNRs, although without evident precipitation. It is 
possible that the different components of RPMI may cooperate to modify the 
microenvironment of the particles, inducing a partial substitution of their PEG portion 
and protein adsorption. However, the extent of red-shift that was observed did not 
preclude the particle capacity to interact with light. In another set of experiments, the 
cytotoxic effects of PEG-GNRs on four tumor cell lines have been studied. Inhibitory 
growth effects occurred only at the highest gold concentrations and after prolonged 
exposures, as long as one week, when structural modifications such as those seen in 
RPMI may intervene. Available literature data are limited to shorter exposures (i.e. 24 or 
48 hours).[54,55]  A modulation of the cytotoxic effects in four cell lines suggests that 
the sensitivity to PEG-GNRs varies from model to model and is especially low for HeLa 
cells. Although HeLa cells are the most popular choice to compare the cytotoxicity of 
particles with different size and surface chemistry,[56] our evidence indicates that the 
inspection of additional cell lines and longer exposures can unveil new effects.  
The cytotoxicity observed at high concentrations and long incubation times may reflect 
the presence of contaminants on the particle surface, such as CTAB and  silver.[58] 
While the identification of CTAB fell below the detection  capabilities of common 
analytic methods, the relative amount of silver was assessed by elemental analysis (Figure 
S5 of the SI section). This measurement confirmed that the silver content is higher for 
smaller particles, which reflects their larger specific surface area. Moreover, in HeLa cells, 
the trend of cellular uptake with particle size is opposite to the weak one observed for 
growth inhibition. In combination with the lack of plasmatic membrane 
permeabilization, these data refute any simple correlation between particle contact and 
cytotoxicity, which is more likely to depend on the release of silver ions and other 
contaminants retained on the particle surface.  
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In other words, the higher content of contaminants in smaller PEG-GNRs seems to over 
counteract the effect of a lower cellular uptake in the final cytotoxicity. An accurate 
quantification of the release of CTAB and silver ions into the cellular media will be the 
focus of future efforts. Notably, according to Figure S5 of the SI, a suspension containing 
100 µM Au also comprises a total content of silver ranging between 0.6-1.6 ppm only, 
which is in the order of the sensitivity of our elemental analysis. The resultant release of 
silver ions falls below our current detection limits.  
In the last set of experiments two parameters that are crucial for the use of PEG-GNRs in 
biomedical applications requiring their intravenous administration have been 
considered. Alkilany et al. reported that blood vessels are not damaged by an exposure to 
PEG-GNRs. [58]  
Here, the absence of haemolysis and rarity of unspecific cellular uptake of PEG-GNRs is 
demonstrated. The latter grows with particle size. Previous studies reported a higher 
uptake for smaller particles.[18,24,31] However those studies extended the range of 
particle sizes much below our GNRs 1/9, which we did not take into consideration 
because of their poor plasmonic behaviour and lack of synthetic methods. Other studies 
reported that the uptake of gold nanospheres displays  a  maximum  for  radii  around 25 
nm. [21,25] These PEG-GNRs with equivalent radii ranging from 5 to 20 nm seem to fit 
in the positive slope of that curve, even though the comparison of spherical and 
cylindrical particles requires some caution. [20] These considerations hold for those cells 
that do not exhibit specific phagocytic functions or conditions such as our HeLa cells. A 
macrophagic cell line was also considered, in order to model the uptake that may follow 
from systemic administration by the mononuclear phagocyte system. In this case, a 
different trend for smaller particles, which is ascribed to a phagocytic activity, was found. 
 !
4. Conclusions 
In conclusion, PEG-GNRs are a stable platform for applications in biomedical optics. 
Their shape governs the frequency of their plasmonic resonances. Instead their size can 
be engineered to optimize the interface with an optical excitation and a biological 
environment for specific uses. Here we focused on the relationships between particle size 
and some biological profiles. 
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Modest PEG-GNRs cytotoxicity appears only at concentrations above  100 µM Au and 
after several days of incubation. This toxicity does not vary much with particle size. 
However some differences may arise from the larger specific surface area of smaller 
particles, which we associate with some contamination originating from the particle 
synthesis. Acute effects, such as membrane permeabilization and haemolysis, were not 
observed for any particle size. Data are coherent within different cell lines and toxicity 
tests, even though some models and parameters are more sensitive than others.  
Future efforts should  focus on the removal of contaminants from PEG-GNRs without 
destabilizing the PEG coating. The cellular uptake of PEG-GNRs is low and displays 
some modulation with particle size. Larger particles (say 85 nm length by 21 nm 
diameter) may be convenient for those contexts that require  unspecific uptake, such as 
for loading of  cellular vehicles,[55,56] while average particles (say 41 nm length by 10 
nm diameter) may be ideal to inhibit unspecific uptake and pursue slower blood 
clearance or specificity by the addition of ligands. All this evidence, together with the 
absence of interactions with albumin, which is the most abundant protein in the plasma, 
suggests that PEG-GNRs are compatible with blood injection. In essence, particle size 
does not overturn the safety and  blood compatibility of PEGylated GNRs in their range 
of greatest biomedical interest, but may still provide alternatives for a fine modulation of 
functional biological profiles. !!
5. Experimental section 
Materials 
Sodium borohydride, cetyltrimethylammonium bromide (CTAB), chloroauric acid, silver 
nitrate, ascorbic acid, alpha methoxy omega mercapto polyethylene glycol (MW 5000), 
polysorbate 20, sulforhodamine B and all chemicals for the various buffer solutions were 
obtained from  Sigma  Aldrich  and  used  as  received.  Cell  culture media (RPMI1640, 
DMEM and F12), fetal calf serum and antibiotics (penicillin, streptomycin) were 
purchased from Gibco. The water for particle synthesis was ultrapure. !!!!
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Synthesis of PEGylated gold nanorods 
Gold nanorods were synthesised at 25°C. A seed suspension  was prepared by rapid 
injection of ice-cold 10 mM aqueous sodium borohydride into a solution containing 100 
mM CTAB and 240 µM chloroauric acid until a final concentration of 560 µM sodium 
borohydride. This suspension was left under vigorous agitation for 10 min and then at 
rest for another 2 hours before rapid addition into a growth solution in different 
amounts. Meanwhile 500 ml growth solution were prepared with 100 mM CTAB, 470 
µM chloroauric acid, 92 µM silver nitrate and 520 µM ascorbic acid. This solution was 
divided into five aliquots with a volume of 100 ml each, before injection of 1.8 (particle 
sample 1/9), 0.59 (1/3), 0.20 (1), 0.066 (3) or 0.022 ml (9) seed suspension ( for particle 
size1/9 see also Chapter 1). After 24 hours, 100 mM aqueous ascorbic acid was added 
until a total content of 710 µM ascorbic acid, which served to complete the metal 
reduction. [9,61] After  two cycles of centrifugation and decantation, particles were 
transferred at a rate of 1.9 mM Au into an acetate buffer at pH 5 containing 500 µM 
CTAB and 50 µM alpha methoxy omega mercapto PEG (MW 5000). The PEGylation 
was left to develop at 37°C for two hours, before centrifugation, decantation and 
resuspension  in 1% (v/v)  aqueous polysorbate 20. This suspension was left at rest for 2 
hours at 37°C, in an attempt to extract possible contaminants. Finally, PEG-GNRs were 
transferred at a rate of 4.0 mM Au into sterile PBS after purification by four cycles of 
centrifugation and decantation with a dead volume ratio of ∼ 1 / 200. !
Stability of PEGylated gold nano rods 
Spectrophotometric studies were performed by a Jasco V-560 spectrophotometer. Optical 
extinction spectra were recorded after dilution of PEG-GNRs either in PBS or RPMI at 
physiological  pH. The final gold concentration in the various suspensions was 100 µM. 
Spectra of PEG-GNRs in PBS were recorded before and after addition of 10 µM BSA, 
lysozyme and cyt c. All spectra were collected over 168 h both at room temperature and 
at  37°C. In order to achieve additional evidence of possible interactions between PEG-
GNRs and proteins in a representative case, 10 µM cyt c was incubated with 100 µM Au 
PEG-GNRs 1 in PBS at 37°C. After 24 hours, the sample was separated by centrifugation 
at 10000 rpm for 13 min, the supernatant was collected and the pellet was suspended in 
PBS. Both components were analyzed by a Varian Cary 50 Bio UV/Vis 
spectrophotometer.  
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Cell growth and viability 
All cellular lines were maintained under standard conditions as described in the SI 
section. For cell growth and viability studies, cells were inoculated into 96-well 
microplates. After 24 h, the medium was replaced with fresh medium containing PEG-
GNRs. The inhibition of cell growth was studied on SKOV3, IGROV-1, A2780/S and 
HeLa cells, according to the sulforhodamine B (SRB) assay described by Skehan et al.[62] 
SRB assay was performed after 72 and 168 h of incubation with PEG-GNRs. For cell 
viability evaluation, the 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) [63] test was conducted after 24 h of exposure to PEG-GNRs. More detail for cell 
growth and viability studies is given  in the supporting information section. !
Cell membrane permeability 
To assess membrane integrity disruption,  after  cell inoculation, the microtiter plates 
were incubated under standard culture conditions for 24 h and then treated with 2.0 µM 
calcein-AM  for 20 min. Then, the medium was replaced with fresh medium containing 
PEG-GNRs with 300 µM Au for 3 h. After  treatment, cells were extensively washed with 
PBS and imaged using a Leica DMI3000B inverted microscope. !
Haemolysis 
For the evaluation of haemolysis, informed signed consent was obtained  and  human 
whole  blood  was  collected  from healthy volunteers. EDTA (1.8 mg/ml)-containing test 
tubes were used to collect the whole blood, which was centrifuged at 3000 rpm for 20 
min. The buffy coat was collected, washed and diluted with normal saline to a 50% 
hematocrit. 100 µl of these samples were added to 3 ml of normal saline (negative 
control), ultrapure water (positive control) and PEG-GNRs suspensions in PBS at 
different concentrations. All samples were incubated at 37°C for 1 h and haemolysis was 
stopped by the addition of 50 µl of 2.5% glutaraldehyde prior to centrifugation at 3000 
rpm for 15 min. Supernatants were collected in 96-well microplates and their absorbance 
at 405 nm was measured using an automated plate reader. !!!!
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Particle composition and cellular uptake by elemental  analysis 
The determination of gold and silver concentrations in the particles was performed in 
triplicate by a Varian 720-ES Inductively   Coupled   Plasma   Atomic   Emission 
Spectrometer (ICP-AES).[64]  Before analysis, 10 µl suspension of PEG-GNRs in PBS 
were digested in PE vials by heating at 80°C for 24 hours with 1 ml aqua regia (HCl 
suprapure grade and HNO3 sub-boiled in 3:1 ratio). HeLa cells and J774a.1 cells that had 
been exposed to PEG-GNRs were digested by heating at 80°C for 24 hours with 1 ml 
aqua regia and 100 µl H2O2 suprapure grade. After digestion, samples were diluted to 5 
ml with ultrapure water, spiked with 4 ppm Ge used as internal standard and analyzed. 
Wavelengths used for Ag, Au and Ge were 328.068, 242.794 and 209.426  nm, 
respectively. Between  samples, a rinse  solution containing 2% v/v HNO3 was used. !
Cellular uptake by electron microscopy 
J774a.1 cells were seeded onto transwell membranes and treated overnight with PEG-
GNRs. Cells were then washed and fixed with   paraformaldehyde (3,6%, 5 min at room 
temperature). Samples were washed with fresh PBS and membranes were cut in triangles, 
post-fixed in 1% osmium tetroxide in PBS at 4°C for 2 h, washed again, dehydrated in a 
graded series of ethanol at room temperature and incubated in propylene oxide (twice, 
30 min each  time). Samples were then incubated in 1:1 mixture of propylene oxide and 
Spurr resin for 24 h at room temperature, next in 1:2 mixture for 1 h at room 
temperature and finally in  pure resin for 1 h at room temperature, 1 h at 45°C and 24 h 
at 70°C. After sectioning and staining with uranyl acetate for 1 h at room  temperature, 
slices were washed and inspected with a Philips CM12 transmission electron microscope. !!!!!!!!!!
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6. Supporting Informations 
Supplementary Methods 
• Cell lines and culture conditions 
For cellular studies, three human ovarian tumor cell lines (SKOV3, IGROV-1 and 
A2780/S), one human cervix carcinoma cell line (HeLa) and one murine monocytic/
macrophagic cell line (J774a.1) were used. A2780/S and IGROV-1 cell lines were 
maintained in RPMI1640 medium, HeLa and J774a.1 cell lines in DMEM medium and 
SKOV-3 cell line in F-12 medium. All cell lines were supplemented with fetal bovine 
serum, 100 units/mL penicillin, and 100 μg/mL streptomycin and maintained under 
standard culture conditions (37°C, 5% CO2, 95% air and 100% relative humidity). 
• Cell growth inhibition studies 
The cytotoxic effects of five different GNRs samples (1/9, 1/3, 1, 3 and 9) were 
evaluated against SKOV3, IGROV-1, A2780/S and HeLa, according to the 
sulforhodamine B (SRB) assay described by Skehan et al.[36]. Exponentially growing cells 
were inoculated into 96-well microplates at specific plating density/well (range 1 – 5 × 
103) according to the various types of cell lines. After 24 h, the medium was replaced 
with fresh medium containing PEG-GNRs for exposure times of 72 and 168 h. Gold 
concentrations in the different suspensions ranged from 0.003 to 100 μM. Cells were 
then fixed in situ by 10% trichloroacetic acid (TCA) and stained by SRB solution at 
0.4% (w/v) in 1% acetic acid. After staining, unbound dye was removed by washing five 
times with 1% acetic acid and the plates were air dried. Bound stain was subsequently 
solubilized with 10 mM tris base and its absorbance was read on an automated plate 
reader at a wavelength of 540 nm. The IC50 gold concentration resulting in a 50% 
reduction  in  the  net  protein  content  in  cells  treated  with  particles  as  compared to 
controls was determined after 72 or 168 h particle exposures. The IC50 data represent 
the mean of at least three independent experiments. 
• Cell viability studies 
Exponentially growing cells were inoculated into 96-well microplates and maintained 
under standard culture conditions for 24 h. Thereafter, the medium was replaced with 
fresh medium containing different concentrations of PEG-GNRs. After 24 h, the MTT 
reduction assay described by Mosmann [41] was performed: cells were incubated with a 
!85
Chapter 3                                                                Size Dependent Biological Profiles of PEGylated Gold Nanorods
0.5 mg/ml MTT solution at 37°C for 4 h and then with cell lysis buffer (20% SDS, 50% 
N,Ndimethylformamide, pH 4.7) for 3 h. The absorbance values of blue formazan were 
determined at 590 nm by an automated plate reader. 
Supplementary data 
Figure S1. Stability of PEGylated gold nanorods with lysozyme. Absorption spectra of five sizes of 
PEG-GNRs in PBS with lysozyme. A) GNRs 1/9; B) 1/3; C) 1; D) 3; E) 9. The figure shows 
spectra recorded at time zero (black line) and after 1 h (green line), 24 h (red line) and 168 h (blue 
line). 
!
Figure S2. Stability of PEGylated gold nanorods with cyt c. Absorption spectra of five sizes of 
PEG-GNRs in PBS with cyt c. A) GNRs 1/9; B) 1/3; C) 1; D) 3; E) 9. The figure shows spectra 
recorded at time zero (black line) and after 1 h (green line), 24 h (red line) and 168 h (blue line). 
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Figure S3. Interaction of PEGylated gold nanorods with cyt c. Absorption spectra of PEG-GNRs 
1 with cyt c incubated for 24 h at 37°C (A) and after centrifugation and washing (B). Supernatant 
obtained after the first washing cycle (C). 
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Figure S4. Membrane integrity. Calcein fluorescence in HeLa (A), IGROV (B) and SKOV3 (C) 
untreated cells and after treatment with PEG-GNRs of different sizes. All samples exhibit no 
release of calcein after treatment with GNRs, indicating that the membrane integrity has not been 
altered. 
!
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Figure S5. Particle composition by elemental analysis. Ratio between Ag and Au among the 
different sizes of PEG-GNRs. 
!
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1. Introduction 
Gold nanorods (GNRs) feature unique and useful optical properties that are highly 
dependent on size and aspect ratio [1-5]. While gold nanospheres absorb mainly in the 
visible region, the localized surface plasmon resonance (LSPR) band of GNRs splits into 
an extinction band in the visible region (due to the transverse plasmon excitation) and a 
second intense band in the vis-NIR region (due to the longitudinal excitation), whose 
position depends critically on the aspect ratio of the particle [6]. These strong 
absorptions open a range of biomedical applications in diagnosis [7,8] and therapy (i.e. 
drug delivery [9] and photothermal therapy [10-12]). In particular, the unique optical 
properties of GNRs make them suitable platforms for sensing applications [13,14]. 
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Specifically, the longitudinal component of the GNR LSPR band is highly sensitive to 
changes in the refractive index of the immediate environment of the GNRs [15,16]. 
Several examples demonstrate how GNRs can be used for biosensing through 
conjugation with biological receptors. Chen et al. [17] and Nusz et al. [18] report the use 
of GNRs functionalized with biotin molecules for the quantitative detection of 
streptavidin through monitoring the spectral wavelength shift of the longitudinal LSPR. 
GNRs modified with antibodies for the detection of specific antigens were likewise used 
for the multiplex biosensing [19]. Several studies have explored the interactions of gold 
nanoparticles [20-22] and nanorods with proteins [23–25] and revealed how the nature 
of the coating is critical to modulate the interface between particles and biomolecules 
[26-29]. This control enables the attachment of additional functional molecules such as 
ligands for biochemical targets of interest [10] and enhances the stability of the particles 
within culture media and body fluids [24]. 
The use of GNRs for both sensing and delivery relies on their stability in biological 
fluids, avoiding deleterious aggregation and precipitation phenomena [30,31]. Studies 
have identified polyethylene glycol (PEG) as the coating of choice for GNRs to achieve 
this goal. PEG-coated GNRs manifest excellent stability and biocompatibility profiles in 
comparison with cetyl trimethylammonium bromide (CTAB)-capped GNRs [32,33]. 
Moreover, PEG-coated GNRs manifest on the whole a far lower reactivity with proteins 
in comparison to CTAB-coated GNRs [33,34]. We hypothesized that modification of 
PEG through attachment of charged groups at their termini could be used to modulate 
the interactions of GNRs with proteins while maintaining colloidal stability. For this 
reason, we prepared two types of PEG-coated GNRs bearing cationic amino (PEG-NH3+) 
or anionic carboxylate (PEG-COO−) groups. Results showed how different functional 
groups on the PEG ligand can modulate the GNR–protein adducts through electrostatic 
interactions and the reversibility of the protein binding process to the GNRs. !!!!!!!!
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2.   Results and Discussion 
Synthesis and characterization of PEG-coated GNRs 
GNRs, of average size 5 nm × 20 nm (aspect ratio 4), were synthesized and functionalized 
with PEG-NH2 (GNR-PEG-NH2) or PEG-COOH (GNR-PEG-COOH) as described 
above. A TEM image of the GNRs obtained following this procedure is shown in Figure 
S1. UV–vis–NIR absorption spectra were recorded for the various types of GNRs in the 
window between 350 and 1000 nm, where two LSPR bands are observed. Surprisingly, 
the maxima of both plasmonic bands are superimposable for the as-synthesized GNRs 
(GNR-CTAB), the GNR-PEG-NH2, and GNR-PEG-COOH  (Figure S2). 
!
Interactions of PEG-coated GNRs with proteins 
The interactions of GNR-PEG-NH2 and GNR-PEG-COOH with three proteins (hCC, 
HEWL and BSA) was then studied using spectrophotometric analysis. As expected, due 
to charge complementarity, a noticeable change occurred when BSA was added to GNR-
PEG-NH2 (Figure 1); an intensity redistribution was noticed leading to a decrease of the 
extinction at the original maximum and a progressive red-shift of the longitudinal LSPR. 
The protein-induced red-shift and asymmetry in the longitudinal LSPR bands can both 
be rationalized on the basis of theoretical predictions [35]. The LSPR of anisotropic 
nanoparticles like GNRs is especially sensitive to changes of the environment dielectric 
function [36,37]. Small changes, in fact, may occur upon water displacement by those 
protein molecules which bind at the water/ammonium PEG coating interface. This 
displacement will lead to an increase of the refractive index [38], and therefore to a red-
shift of the longitudinal LSPR band position. The intensity redistribution, whereby the 
intensity of the longitudinal band is decreased and a broad extinction at longer 
wavelengths (> 900 nm) appears (Figure 1), indicates the formation of a considerable 
amount of plasmonically coupled GNR aggregates [39]. The shift to longer wavelengths 
is a strong indication for the prevalence of end-to-end dimers [35]. 
!
!
!
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Figure 1. UV-vis-NIR spectra of GNR-PEG-NH2 (15 nM) in water before and after the addition of 
BSA at different concentrations. 
Figure 2. Plot of the extinction change (ΔAbs) measured at the maximum of the longitudinal 
LSPR of GNR-PEG-NH2 (A) and GNR-PEG-COOH (B) and of longitudinal LSPR shift (Δλ) of 
GNR-PEG-NH2 (C) and GNR-PEG-COOH (D) at different proteins concentration. 
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Figure 2 reports the spectral effects produced by addition of BSA, hCC or HEWL, 
showing a different behavior for the three proteins. Small changes were detected in the 
extinction spectra of GNR-PEG-NH2 with increasing concentrations of cationic hCC 
and HEWL (Figure 2A). In particular the longitudinal LSPR shift (Δλ) of GNR-PEG-
NH2 did not show any differences upon interaction with both cationic proteins (Figure 
2C). The intensity of the longer-wavelength band of GNR-PEG-NH2 decreased upon 
addition of the two model proteins with a small red-shift. Therefore, a similar behavior 
can be ascribed to the interaction between GNR-PEG-NH2 and hCC or HEWL. 
However, in the presence of GNR-PEG-COOH, different patterns can be assigned to the 
three proteins (Figure 2B and D). As expected, the interaction between GNR-PEG-
COOH and BSA was negligible; only a minimal intensity decrease of the longer-
wavelength band was observed when BSA was added to aqueous dispersions of GNR-
PEG-COOH while hCC and HEWL showed greater spectroscopic changes. HEWL has a 
net positive charge under all applied experimental conditions, as its isoelectric point is 
11.3. As a consequence, the interaction with GNR-PEG-COOH is favored (Figure 2B 
and D) whereas the extinction spectra of GNR-PEG-NH2 are changed to a very limited 
extent (Figure 2A and C). Remarkably the interaction with GNR-PEG-COOH was 
particularly evident at low concentrations of the protein, leading to an increase of the 
extinction and a consistent red-shift of the longitudinal LSPR as a consequence of the 
alteration of the GNRs local environment and the dielectric constant of the medium 
[16]. At higher concentrations of HEWL a decrease of the extinction at the maximum 
was detected, possibly due to the formation of aggregates. The extinction changes in the 
presence of HEWL were not so pronounced as in the case of BSA, suggesting that the 
HEWL-induced GNR aggregates were less abundant and/or less ordered. The results 
obtained in the case of hCC were similar to those obtained with HEWL: the intensity of 
the longitudinal LSPR band progressively decreased—and the maximum slightly red-
shifted—upon addition of hCC to GNR-PEG-COOH sample. hCC, like HEWL, is 
positively charged in water solution or in PB solutions at pH 7.4, its isoelectric point 
being about 10.5. Then hCC appeared to interact mostly with the negatively charged 
GNRs, leading to a larger decrease of the extinction compared to HEWL (Figure 2B and 
D). Similar experiments performed in 50 mM PB showed that the spectral changes were 
largely suppressed or attenuated for both functionalized GNRs upon addiction of 
HEWL (Figure S3), hCC (Figure S4) and BSA (FigureS5), as expected due to electrostatic 
screening effects at higher salt concentrations [40]. 
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Effects of electrolyte addition on GNR–protein interactions 
In most above cases, a clear effect of the buffer was detected. To separate pH effects from 
ionic strength effects, we have studied the interaction of BSA with GNR-PEG-NH2 that 
produces the largest spectral variations, in the presence of a salt. Figure 3 shows the 
extinction changes occurring upon addition of BSA to GNR-PEG-NH2 in a 50 mM 
sodium sulfate solution (Figure 3A) and after the addition of sodium sulfate to an 
already formed BSA/GNR-PEG-NH2 conjugate (Figure 3B). It was apparent that the 
interaction was then largely inhibited by the presence of salt. In fact, as it was shown in 
pure water (Figure 1), both the longer-wavelength band and the shorter-wavelength one 
became asymmetric, leading to a decrease of the extinction and an increase on the red 
side of the LSPR band. In particular, an isosbestic point can be seen in Figure 1, 
indicating an equilibrium between two species, that are GNRs and end-to-end dimers, 
while in the presence of salts (Figure 3A) only a decrease in the intensity could be 
detected. Moreover, sodium sulfate almost completely reversed the spectral changes when 
it was added to an already formed BSA/GNR-PEG-NH2 conjugate (Figure 3B).  
Figure 3. UV-vis-NIR spectra of GNR-PEG-NH2 (15 nM) in 50 mM Na2SO4 solution in the 
presence of BSA at different concentrations (A) and of GNR-PEG-NH2, in the presence of BSA 
10−5 M and after the addition of 50 mM Na2SO4 (B). 
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Therefore, GNR-PEG-NH2 can be easily separated from the adsorbed protein, indicating 
that any chemical bonds are formed between the gold surface and protein cysteine 
residues, owing to the PEG layer. These results are consistent with the recently reported 
distinct interactions between BSA and either positively or negatively charged GNRs [40] 
and demonstrate the importance of electrostatic interactions. Moreover, the observation 
that a small fraction of BSA is irreversibly bound, whereas most protein molecules can be 
displaced by the addition of sodium sulfate is compatible with the formation of both a 
“hard” and a “soft” protein corona [41]. 
!
DLS and CD measurements 
To correlate the protein-induced GNR extinction changes with GNR size parameters, we 
performed DLS measurements of the most representative sample, namely, GNR-PEG-
NH2, upon interaction with BSA. Results are reported in Figure 4 while the 
hydrodynamic radius and the relative intensity of the DLS peaks are summarized in 
Table 1.  
!
Table 1. Hydrodynamic diameter of GNRs-PEG-NH2 and intensity percentage of DLS peaks 
before and after the addition of increasing concentrations of BSA 
!
!
!
!
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Figure 4. Size distribution curves of GNR-PEG-NH2 (15 nM) in water before and after the 
addition of increasing concentrations of BSA. 
The size distribution diagram of GNR-PEG-NH2 in Figure 4 shows two peaks, one at 1.4 
nm and the second one at 50-60 nm. According to the literature [42,43], the small size 
distribution peak is not an actual particle size but a representation of the rotational 
diffusion of nanorods while peak at 50-60 nm is the hydrodynamic diameter of GNRs. 
Upon addition of BSA, a progressive increase of the hydrodynamic radius of GNR-PEG-
NH2 was observed (Figure 4). Moreover the relative intensity of the small size peak 
decreased from 21.5% to 0%, while the relative intensity of the large size peak increased 
from 78.5% to 100%. The increase in the hydrodynamic radius points to the progressive 
formation of protein layers, wrapping the GNRs, which will partly stay in their 
monomeric form and partly form GNR aggregates. Moreover the small size DLS peak, 
due to the rotational diffusion of rod-like nano-particles, disappeared upon addition of 
BSA beyond 5 × 10−6 M (Figure 4). This indicates that the large-sized protein/GNR 
aggregates, formed at high BSA concentrations, were essentially spherical, as previously 
observed in similar cases [43,44]. For comparison purposes, DLS measurements of GNR-
PEG-COOH interacting with hCC were performed. The size distribution peaks are 
reported in Figure S6 and summarized in Table S2. In the case of GNRs-PEG-COOH, a 
significant increase of the hydrodynamic diameter could be observed only above 3×10−7 
M protein concentration. This contrasts with the extinction results, where a small change 
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was observed already at 3×10−8 M hCC concentration. However DLS data of GNR-PEG-
COOH in PB (Figure S7 and Table S3) showed a good agreement with the 
spectrophotometric measurements. In fact the presence of phosphate both hindered the 
protein-induced extinction changes, and suppressed the increase of the hydrodynamic 
radius that, in contrast, is clearly observed in the absence of  phosphate.  
Then, CD measurements were performed to determine the effect of GNR–protein 
interaction on the protein structure. Figure 5 compares the CD spectra—in the 200–260 
nm  range—of  BSA  at  3 ×10− 7  M and  9×10−7 M before and after the addition of GNR-
PEG-NH2. The interaction led to an intensity decrease of the negative bands at 209 and 
222 nm for the lower protein concentration (Figure 5A), whereas the CD spectra at 
9×10− 7 M protein are not changed by the presence of GNRs but for a small baseline 
offset (Figure 5B). This can be explained considering that the CD spectra at higher BSA 
molarity result from  all the protein molecules, including the unbound ones and those 
lying in the outer layers around the GNRs. Therefore, the contribution of the unaltered 
BSA molecules to the measured CD will be relatively more important at higher protein 
concentrations and overwhelm the CD decrease due to GNR–protein interaction. In 
fact, it has been previously observed that surface-induced CD changes are best observed 
at very low protein concentrations [45,46]. 
Interestingly, the GNR-induced changes were not restored by addition of sulfate, in 
contrast to the extinction changes (Figure 6), indicating a partially irreversible loss of α-
helical structure. Both the observed spectral changes (Figure 1) and the irreversibility 
showed in the CD spectra (Figure 6) were similar to those induced in BSA by adsorption 
to, and desorption from, polystyrene sulfonate particles [47]. Moreover, CD decrease has 
been reported in a previous study on the interaction of BSA with CTAB-coated GNRs 
[24]. In that case, the incubation temperature was 65 °C, that possibly further 
destabilized the protein secondary structure. 
!
!
!
!
!
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Figure 5. CD spectra of BSA 3×10− 7 M (A) or 9×10− 7 M (B) recorded in water and in the 
presence of GNR-PEG-NH2 (15nm). 
Figure 6. CD spectra of BSA, in the presence of GNR-PEG-NH2 (15 nM) and after the addition 
of Na2SO4. 
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Surface-induced protein unfolding has been discussed for different kinds of surfaces, 
including nanostructured surfaces [48]. After the formation of contacts at the surface/
solvent interface, the interactions between protein and surface are optimized to some 
extent. This process can involve, besides other interactions, protein structural 
rearrangements. Irreversible protein changes can occur at this stage, depending on the 
type and strength of the surface/protein interaction. Restoring protein solvation, which 
is more frequently obtained by dilution, or—as in our case—by charge neutralization, will 
lead to the solubilization of a protein form, which, in some cases, will not completely 
refold. Noticeably, the irreversibility of BSA secondary structure changes is not correlated 
with that of GNR-BSA binding which, in fact, is almost complete. 
!
3. Conclusions 
A comprehensive view of the reported results demonstrates quite unambiguously that the 
interactions between differently functionalized GNRs, on one side, and a few 
representative proteins, on the other, are mainly determined by the electrostatic 
properties of the interacting moieties—and, in addition, by the presence of electrolytes in 
solution. These interactions were analyzed in the case of three proteins: hCC, HEWL, 
and BSA. The interactions between the three proteins and the two kinds of 
functionalized GNRs appeared exemplary and clearly supported the Coulombic nature 
of the interaction. The case of the 
BSA/GNR-PEG-NH2  complexes is the most relevant one. The interaction gave rise to i) 
LSPR extinction changes of both the transverse and longitudinal mode bands, ii) a 
concentration-dependent increase of the hydrodynamic radius, and iii) a net decrease in 
protein CD signal. In summary, the interaction between BSA and the surface of GNR- 
PEG-NH2 can be schematically depicted as protein adsorption followed by partial 
unfolding. As in the case of the smaller proteins, we propose that the driving force for 
adsorption is the Coulombic interaction between GNR-PEG-NH2, bearing a positively 
charged ammonium group, and the negatively charged BSA. The importance of 
electrostatic interactions is underscored both by the inhibitory effect of sodium sulfate 
on the interaction and by the extremely reduced extinction changes, observed when BSA 
was added to the negatively charged GNR-PEG-COOH. 
We like to stress how the irreversibility of the secondary structure changes, observed for 
BSA, was not accompanied by irreversible BSA/GNR-PEG-NH2 interactions.  
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To our knowledge, the strong influence of electrolytes on the interaction between 
proteins and functionalized nanoparticles - here highlighted- had not been investigated 
in depth so far, and  offers  strong  evidence  for  the  importance  of  the  role  of 
electrostatics in these interactions. In conclusion, the type of functionalization can direct 
quite selectively proteins binding to GNRs, leading to different interaction patters and 
providing useful hints for protein sensing applications. !!!
4. Experimental section 
Materials 
Sodium borohydride, CTAB, chloroauric acid, silver nitrate, ascorbic acid, O-(3- 
carboxypropyl) -O″-[2- (3- mercaptopropionylamino) ethyl]-polyethylene glycol (MW 5000, 
HS-PEG-COOH), polysorbate 20 as well as all chemicals for the various buffer solutions 
were purchased from Sigma Aldrich. Thiol-PEG-amine (MW 5000, HS-PEG-NH2) was 
purchased from Ibis  Technologies. Horse heart cytochrome c (hCC, C7752) and chicken 
hen egg white lysozyme (HEWL, L-7651) were purchased from Sigma Aldrich. Bovine 
serum albumin (BSA) was purchased from Fluka (5470). Spermine and sodium sulfate 
were purchased from Merck. All the chemicals and proteins were used as received 
without further purification and the solutions were prepared with deionized water 
produced by a Millipore system. !
Synthesis of gold nanorods 
PEG-coated GNRs. GNRs  with longitudinal LSPR band centered at 800 nm (5 nm×20 
nm, aspect ratio 4) were synthesized by a seed-mediated CTAB- assisted reduction of 
chloroauric acid with ascorbic acid, according to Nikoobakht and El-Sayed [50] and 
modified by Ratto et al. [51,52]. Then GNRs were separated from the reaction by-
products through centrifugation [53] and functionalized with HS-PEG-COOH or HS-
PEG-NH2 following the procedure by Tatini et al. [51]. 
!
!
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UV–vis–NIR spectrophotometry 
UV–vis–NIR spectra were recorded with a double-beam Cary 5 (Varian, Palo Alto, CA, 
USA) spectrophotometer in the range 1000–350 nm at room temperature in a 1 cm path 
length PE cuvettes and using Cary WinUV Scan software. Light extinction spectra were 
recorded after dilution (1:20) of the functionalized GNRs in Milli-Q water at pH 5.2 or 
50 mM phosphate buffer (PB) at physiological pH.  The final GNR concentration was 15 
nM. The spectra were recorded before and after the addition of BSA, HEWL or hCC at 
increasing  concentrations (3×10−8  M,  3×10− 7 M, 3×10− 6 M, 5×10− 6 M and 10− 5 M). 
All the spectra were collected at room temperature immediately after the addition and 
mixing of the protein in the sample. !!
Dynamic light scattering measurements 
DLS was performed on a zeta potential/particle sizer (Malvern Nano ZS90) to determine 
the distribution of the hydrodynamic diameters of the functionalized GNRs and of 
aggregates eventually formed after the addition of the protein. Samples were prepared 
following the same procedure described for UV–vis–NIR spectrophotometry in 1 cm 
path length PE cuvettes. !
Circular dichroism (CD) measurements 
CD spectra were recorded at 25 °C with a Jasco J-810 spectropolarimeter equipped with a 
Peltier type temperature control system (Jasco PTC-4235) in a 1 cm path length quartz 
cell and using Spectra Manager software. Briefly, measurements were performed in  Milli-
Q water (1 ml) at pH 5.2 with GNR-PEG-COOH or GNR-PEG-NH2 (15 nM) and 
increasing concentrations of BSA (9×10−8 M to 1.2×10−6 M). The instrumental 
conditions are reported in Table S1. !
!
!
!
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6. Supporting Informations 
Figure S1. TEM images of GNR-CTAB of average size 5 nm x 20 nm, aspect ratio 4. Scale bar: 50 
nm. 
!
Table S1. CD measurements operating conditions. 
Figure S2. UV-vis-NIR spectra of GNR-CTAB, GNR-PEG-NH2, and GNR-PEG-COOH in Milli-
Q water. 
!
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Figure S3. UV-vis-NIR spectra of GNR-PEG-NH2 (15nM) in water (A) or in PB (C) and GNR-
PEG-COOH in water (B) or PB (D). Specifically, spectra were recorded before and after the 
addition of HEWL at different concentrations. The inset in panel B shows the shift of the 
longitudinal LSPR band as a function of the HEWL concentration. 
!
!
!
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Figure S4. UV-vis-NIR spectra of GNR-PEG-NH2 (15 nM) in water (A) or in PB (C) and GNR-
PEG-COOH in water (B) or in PB (D). Specifically, spectra were recorded before and after the 
addition of hCC at different concentrations. 
!
!
!
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Figure S5. UV-vis-NIR spectra of GNR-PEG-NH2 (15nM) in water (A) or in PB (C) and GNR-
PEG-COOH in water (B) or PB (D). Specifically, spectra were recorded before and after the 
addition of BSA at different concentrations. 
Figure S6. Size distribution curves of GNR-PEG-COOH (15nM) in Milli-Q water before and after 
the addition of increasing concentrations of hCC. 
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Table S2. Hydrodynamic diameter and intensity percentage of DLS peaks relative to GNR-PEG-
COOH before and after the addition of increasing concentrations of hCC in Milli-Q water. 
 !
Figure S7. Size distribution curves of GNR-PEG-COOH (15nM) in PB before and after the 
addition of increasing concentrations of hCC. !!!!!!!!!!!!
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Table S3. Hydrodynamic diameter and intensity percentage of DLS peaks relative to GNR-PEG-
COOH before and after the addition of increasing concentrations of hCC in PB. 
 !!
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Gold Nanorod-Stabilized Nanocapsules for the Delivery of 
Anticancer Drugs* !!
* Unpublished results from a work in collaboration with Dr. Chang Soo Kim, Ms Gülen 
Yesilbag, Mr Ryan F. Landis, and Prof. V. M. Rotello (University of Massachusetts, 
Amherst). !
Graphical abstract 
1. Introduction 
Drug delivery systems (DDS) provide safe platforms for delivery of different 
pharmaceutical compounds, improving their therapeutic effect through controlled 
release properties. Targeting of therapeutics specifically to tumors further enhances the 
efficacy of these treatments, while minimizing side effects. There are three major 
strategies for targeting. Active targeting to cell-surface receptors provides an obvious 
strategy, [1] that has been challenging to implement. [2] Passive targeting uses particles 
that are small enough (between 10 and 200 nm) to avoid capture of the DDs by 
macrophages of the reticuloendothelial system. [3] Due to their nanoscale size (<200 
nm), these systems can take advantage of the “enhanced permeability and retention 
(EPR) effect”, accumulating preferentially in tumor tissues due to the leaky vasculature 
found there. [4] The final strategy is through external control of therapeutic action, 
providing the potential for pin-point accuracy in targeting. [5]  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Nanocapsules (NCs) provide a versatile DDS platform, providing promising tools for 
drug delivery. [6] Most of these systems are comprised of lipids and/or polymers self-
assembled into capsules with aqueous interiors. [7] Recently, gold nanoparticle (GNP)-
stabilized NCs (GNP-NCs) have been demonstrated to deliver proteins and small 
molecule drugs directly into the cytosol. [8-10] In these systems, nanoparticles are 
assembled at the interface of an oil-in-water nanoemulsion through specific 
supramolecular interactions between GNPs and the oil droplet. [8] These GNP-NCs 
feature excellent stability and low toxicity, and demonstrate an efficient delivery of drugs 
and proteins into the cytosol leading to cellular apoptosis. [10] Additionally, their size 
(∼100 nm) makes them ideal for utilizing the EPR effect. 
Recent studies by Rotello have demonstrated that composite films containing gold 
nanoparticles and polyamidoamine (PAMAM) dendrimers allows tuning of the release 
profile of the loaded drug by changing dendrimer ratio and generation. [11,12] In 
particular, lower generation dendrimers show a faster doxorubicin release than higher 
generation analogs. Translating these films onto the surface of AuNPNCs provides a 
platform with readily tunable release properties in unpublished results by the Rotello 
group.  
Replacing the spherical particles in GNP-NCs with nanorods (GNRs) would provide 
NCs with unique optical properties that would allow external control of drug release. In 
particular, GNRs feature an absorption in the near IR region (longitudinal surface 
plasmon resonance, LSPR) of the spectrum that can be tuned between 650 nm and 1100 
nm. [13] Due to this intense longitudinal absorption, GNRs are able to efficiently 
convert NIR light into localized heat. This tunability in absorption allows GNRs to be 
heated at wavelengths where tissue features minimal absorption and scattering, allowing 
excellent deep-tissue heating of these systems. [14] This ability to localize heating provides 
an effective targeting tool, making GNRs of great interest for photothermal treatment of 
cancer. [15] Therefore, the goal of the present project is to integrate the controlled 
release properties of the current GNP-NCs systems with the NIR heating capabilities of 
GNRs, providing DDS with highly specific spatiotemporal therapeutic action. !!!!
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Specifically, the present chapter reports: 
- Synthesis, characterization and functionalization of small sized GNRs. 
- Self-assembling of these GNRs onto fatty acid nanodroplets to provide 100-200 nm 
GNR-NCs and GNR-NCs loaded with the anticancer drug paclitaxel (PTX). 
- Crosslinking of these GNR-NCs with a dendrimer. 
- Demonstration of the structural and colloidal stability of GNR-NCs in physiological 
conditions.  
- In vitro cytotoxicity of GNR-NCs and PTX loaded nanocapsules. !
Further studies will be focused on the optimization of the NIR photorelease properties 
of the GNR-NCs in solution and on the in vitro effectiveness of the photothermal 
release against breast tumor cells, focusing on cell uptake and effective release of 
therapeutics. 
!
2.   Results and Discussion 
Synthesis, characterization and functionalization of GNRs  
Small GNRs (∼20 nm length) are essential to obtain GNR-NCs with an optimal size for 
drug delivery purpose (100-200 nm). These small gold nanorods were synthesized 
following the seed-mediated method according to Nikoobakht et al., [16] with 
appropriate modifications to obtain smaller-sized GNRs as reported in Chapter 1. The 
optical properties of GNRs have been assessed through UV-vis spectroscopy, and the size 
evaluated by measuring the width and length of particles using transmission electron 
microscopy (TEM) imaging (see Chapter 1). After synthesis, GNRs were purified with a 
two-step centrifugation method, as reported in Chapter 2, to remove the excess cytotoxic 
cetyltrimethylammonium bromide (CTAB) required for their formation, and to separate 
GNRs from other reaction by-products. [17] The GNRs were then functionalized with a 
ligand bearing an arginine (Arg) group (Figure 1), designed to allow the NCs formation. 
[18] The functionalization was performed with a two-step procedure optimized for the 
GNR’s size of interest (see the “Experimental section”for details). 
!
!
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 !
Figure 1. Schematic representation of GNR’s functionalization with Arg ligand. !!!
Firstly, GNRs were functionalized with HS-PEG5000 to stabilize GNRs, [19] and, 
thereafter, thiol exchange with the selected arginine ligand, was performed. Then GNRs 
were washed to remove the remaining displaced CTAB from GNRs functionalized with 
the arginine ligand (Arg-GNR). The characterization of Arg-GNRs was performed 
through UV-vis spectroscopy (Figure 2A) and TEM imaging (Figure 2B). Functionalized 
GNRs showed the same size of CTAB-coated GNRs, while the LSPR of GNRs was 15 
nm red-shifted, according to literature. [20] Moreover, laser desorption ionization mass 
spectrometry (LDI-MS) was used to assess the effective functionalization and the 
complete removal of CTAB (Figure 3). [21] Specifically, in the LDI mass spectrum, peaks 
referred to CTAB (i.e. 285 m/z) or PEG (i.e. 5000m/z) were not detected. However small 
amount of PEG may not be detected through LDI-MS due to ionic suppressions. 
Therefore the complete thiol exchange can not be staten. !
!
!
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Figure 2. Extinction spectra of GNRs before and after functionalization with the Arg ligand (A) 
and TEM image (B) of Arg-GNRs. Scale bar: 100nm 
Figure 3. LDI mass spectrum of GNRs after functionalization with the arginine ligand. a) is a 
fragment of the Arg ligand with Na+ (C15H31NaO3S) b), d), and e) are peaks presumably due to 
chemical transformations of the Arg ligand during LDI; f) is the Arg ligand, and g) is due to 
chemical transformation of Arg group in the N-hydroxyarginine. [22] 
!!!!
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Fabrication and characterization of GNR-stabilized NCs 
To generate nanoscale GNR-stabilized NCs, the method reported by Rotello et al. have 
been used and adapted to Arg-GNRs. [8] The strategy relies upon nanoscale oil droplet 
stabilization through supramolecular interactions between the GNRs that constitute the 
GNR-NCs shell with the “oil” interior. The well-known arginine-carboxylate hydrogen 
bonding/electrostatic interaction [23-24] was exploited through use of biocompatible 
linoleic acid  as the “oil” interior and Arg-GNRs as the nanoparticle shell (Figure 4). 
GNR-stabilized NCs were fabricated by a two-step procedure. Firstly, template oil 
droplets with a size below 200 nm were generated by agitating linoleic acid in 5 mM 
phosphate buffer (PB) at pH 7.4 in the presence of a small amount of Arg-GNRs using a 
commercial homogenizer.  
!
Figure 4. Fabrication of GNR-stabilized NCs. A) Generation of nanosized oil-in-water droplets 
followed by interfacial assembly of Arg-GNRs. B) Interface of the oil-in water emulsion. C) 
Supramolecular interactions between Arg-GNRs and linoleic acid through arginine-carboxylate 
hydrogen bonding/electrostatic interactions. 
!
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In the second step, the droplets were transferred into a solutions of Arg-GNRs, resulting 
in essentially instantaneous assembly of the Arg-GNRs at the droplets surface through 
Arg-carboxylate interactions. The GNR-NCs formation was optimized by varying the 
ratio between linoleic acid and Arg-GNRs as well as the Arg-GNR/droplet ratio (see 
“Experimental section”). The resultant assemblies were then characterized by UV-vis 
spectroscopy (Figure 5A) and TEM (Figure 5B). At the optimum GNR/droplet ratio, 
TEM image shows essentially no free GNRs on the sample grid and almost spherical 
assemblies of packed Arg-GNRs. Since TEM samples were obtained by drying a small 
amount of the GNR-NCs solution on a TEM grid, the size of the nanocapsules may be 
affected by the drying process. Therefore, DLS measurements were performed to evaluate 
the size of GNR-NCs. The hydrodynamic diameter of GNR-NCs was 144 nm. 
Paclitaxel (PTX)-loaded GNR-NCs were prepared following the same procedure, adding 
PTX into the linoleic acid, where it is solubilized due to the hydrophobicity of PTX. [8]  
Due to the interactions between the Arg group of Arg-GNR and the carboxylate group of 
the linoleic acid, the extinction spectrum of GNR-NCs shows a relevant red-shift of the 
LSPR compared to Arg-GNRs (Figure 5A). In fact it is well-known that an alteration of 
the GNR’s local environment as well as the plasmon coupling between GNRs induce a 
shift of GNR’s plasmon resonance. [25,26] !
Figure 5. Extinction spectra of GNR-NCs and Arg-GNRs (A), and TEM image of GNR-NCs (B) 
obtained at the optimum Arg-GNR/droplets ratio. Scale bar: 200nm. 
!!!
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Crosslinking of GNR-NCs with polyamidoamine dendrimer 
In order to generate ideal platforms for PTX release, GNRs in NCs were crosslinked with 
4th generation (G4) polyamidoamine (PAMAM) dendrimer (Figure 11) using 
dithiocarbamate (DTC) chemistry (Figure 6), providing NCs that are stable to pH, 
temperature and ionic strength variations. [27] After crosslinking, GNR-NCs were 
washed through centrifugation, allowing removal of “free” GNRs and other potential by-
products. Table 1 shows the hydrodynamic diameter of GNR-NCs crosslinked with 
different molar ratio between the dendrimer linkers and GNRs.  
Figure 6. Schematic representation of the DTC crosslinking of GNR-NCs. 
Table 1. Hydrodynamic diameter of GNR-NCs before and after crosslinking with G4 PAMAM 
dendrimer at different dendrimer/GNR molar ratio.  
* GNR-NCs before (A) and after crosslinking with G4 PAMAM dendrimer at dendrimer/
GNR ratio of 0.25 (B), 0.50 (C) and 1.00 (D). 
!126
Sample* Hydrodinamic diameter 
(nm)
A 144
B 159
C 167
D 210
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GNR-NCs crosslinked with the dendrimer were bigger than GNR-NCs. However the size 
was still reasonable to be used for drug delivery. Moreover it is evident that increasing 
the dendrimer/GNR molar ratio the GNR-NCs’ hydrodynamic diameter increased as 
well, consistent with a higher amount of crosslinked dendrimer on the NCs surface. 
Crosslinked GNR-NCs were then characterized using UV-vis spectroscopy and TEM. 
After crosslinking, NCs maintain the optical properties (Figure 7) as well as the shape of 
GNR-NCs (Figure 8). 
!
!
!
!
!
!
!
!
Figure 7. Extinction spectra of GNR-NCs before (A) and after crosslinking with G4 PAMAM 
dendrimer at dendrimer/GNR ratio of 0.25 (B), 0.50 (C) and 1.00 (D). 
Figure 8. TEM images of GNR-NCs before (A) and after crosslinking with G4 PAMAM 
dendrimer at dendrimer/GNR ratio of 0.25 (B), 0.50 (C) and 1.00 (D). Scale bars: 200nm. 
!
!
!
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Structural and colloidal stability of GNR-NCs and crosslinked GNR-NCs in 
physiological conditions. 
The stability in PB and in 50% serum of both GNR-NCs and GNR-NCs crosslinked 
with 25% G4 PAMAM dendrimer was then evaluated through UV-vis spectroscopy and 
DLS measurements over 24 hours. Due to the relevant absorption of serum, extinction 
spectra were recorded only in PB. Figure 8 shows a red-shift of the LSPR band of GNR-
NCs, possibly due to reorganization of the structure, while the extinction spectrum of 
crosslinked GNR-NCs did not show significant changes in the LSPR band. In fact, DLS 
measurements (Table 2) revealed that in PB the hydrodynamic diameter of GNR-NCs 
was significantly increased respect to crosslinked GNR-NCs.  
Moreover, GNR-NCs aggreagated and deposited at the bottom of the cuvette in the 
presence of 50% serum, while crosslinked GNR-NCs showed only an increase in the size, 
presumably due to interaction/adsorption of proteins on nanocapsules surface. 
Therefore, the high stability of crosslinked GNR-NCs under physiological conditions 
makes them potentially useful as delivery vehicles. 
!
Figure 8. Extinction spectra of GNR-NCs (A) and crosslinked GNR-NCs (B) in 10 mM PB over 
24h. 
!
!
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Table 2. Hydrodynamic diameter of GNR-NCs and crosslinked GNR-NCs in PB and 50% serum 
over 24 hours at 37°C.  
!
!
3. Preliminary in vitro studies 
Preliminary studies of cellular delivery and citotoxicity of nanocapsules were performed. 
To test the delivery, GNR-NCs loaded with Nile Red fluorophore were incubated with 
HeLa cells, and payload delivery followed with a fluorescent microscope. As shown in 
Figure 9, a strong red fluorescence originated from nile red was evenly distributed 
thorough the whole cell cytosol, indicating an efficient and non-endosomal uptake of the 
dye (Figure 9B). Moreover, cells did not show any obvious morphology change after 
delivery, highlighting the bio-compatibility of the delivery vehicle (Figure 9A). 
!
Figure 9. Delivery of Nile Red encapsulated GNR-NCs in HeLa cells.a) Bright field and b) red 
channel fluorescent microscopy images. 
!
!
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Sample Hydrodinamic diameter (nm)
PB 
t=0
PB 
t=24h
50% serum 
t=24h
GNR-NCs 144 310  - -
Crosslinked 
GNR-NCs 
159 164 265
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There are two potential mechanisms for this payload delivery. In the first mechanism, 
material is transferred through membrane fusion from GNR-NCs to the cell without 
nanocapsules uptake, while in the second one, the cell takes up the nanocapsule through 
an endocytotic mechanism, with payload release occurring inside the cell. Previous 
studies on GNP-NCs have shown that the payload delivery follows the nanocapsule-cell 
fusion mechanism. [8] However, further studies to confirm this hypothesis has to be 
performed. 
In an other experiment, the efficacy of nanocapsules as drug delivery systems was 
investigated in cell culture models. Alamar Blue viability essay and HeLa cells were used 
to determine the cytotoxicity of GNR-NCs and crosslinked GNR-NCs compared to the 
PTX-loaded nanocapsules. Figure 10 shows the cell viability of HeLa cells incubated with 
different concentrations of GNR-NCs and crosslinked GNR-NCs, with and without 
PTX.  
!
Figure 10. Cytotoxicity of GNR-NCs and crosslinked GNR-NCs compared to PTX-loaded 
nanocapsules at different concentrations. Cell viability was measured by Alamar Blue assay after 
24 h incubation of nanocapsules with HeLa cells. Log (C) refers to concentration of NCs. See 
Experimental section for calculations of nanocapsules’ concentration. 
!
!
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Both GNR-NCs and crosslinked GNR-NCs featured no non-specific cytotoxicity at the 
concentrations studied, while PTX loaded nanocapsules showed different cytotoxicity 
profiles. Specifically crosslinked PTX-loaded GNR-NCs were less cytotoxic than non-
crosslinked one, indicating that PTX release may be inhibit thanks to the crosslinking of 
NCs with PAMAM dendrimer. In particular the IC50 value for the encapsulated drug was 
234 nM for GNR-NCs and 741 nM for crosslinked GNR-NCs, as compared to 7.6 nM 
for free PTX. [8] Therefore, other than crosslinked nanocapsules, GNR-NCs, may inhibit 
PTX release, contrary to GNP-NCs (IC50 of PTX was 15.8 nM). This difference may be 
due to the different structure of GNR-NCs compared to 2 nm GNP-stabilized 
nanocapsules. However, further studies have to be performed to confirm this hypothesis. 
!!!!!!!!!!!!!!!!!!!!!
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4. Conclusions and Future work 
In summary, the strategy to develope GNP-NCs has been adapted to produce GNR-
stabilized NCs with a size below 200 nm. GNR-NCs have also been crosslinked with G4 
PAMAM dendrimer to provide NCs that are stable in physiological conditions. 
Moreover, crosslinked GNR-NCs have been designed to be safe platforms for delivery 
and to promote the PTX release upon laser activation. In fact, nanocapsules did not 
show potential nonspecific NCs cytotoxicity on HeLa cells, while PTX-loaded crosslinked 
nanocapsules showed a different cytotoxicity profile compared to PTX-loaded GNR-NCs, 
suggesting that crosslinking may inhibit PTX release.  
Further studies will be performed to characterize the potential PTX photorelease in 
solution and the in vitro effectiveness of the photorelease against HeLa cells. 
!
Characterization of photorelease in solution 
The PTX release behavior of the crosslinked capsules will be controlled by adjusting the 
molar ratio between dendrimer linkers and GNRs. NCs crosslinked with varying 
amounts of dendrimer will be placed in a dialysis cassette, and PTX release monitored by 
high-performance liquid chromatography (HPLC) of the surrounding solution. The PTX 
release rate is expected to decrease upon increasing the dendrimer:GNR ratio 
(unpublished results by the Rotello group). Thereafter crosslinked capsules, showing 
little/no release, will be chosen to evaluate the ability of NIR irradiation to promote the 
release of PTX. The NIR photorelease will be optimized by changing laser irradiation 
time and power, with the goal of effective PTX release with minimal NIR flux. 
In vitro effectiveness of the photothermal release against breast cancer cells 
GNR-NCs and PTX-loaded GNR-NCs will be tested in vitro on HeLa cells and, 
thereafter on MCF-7 (human breast cell line), focusing on both potential nonspecific 
NCs cytotoxicity as well as ability of the NIR irradiation to efficiently release PTX. The 
goal is to create carriers with low levels of non-specific toxicity and able to promote drug 
release upon laser activation. Firstly, the effects of the key components will be tested on 
the viability of the cell lines: 1) Arg-GNRs alone; 2) linoleic acid alone; 3) GNR-NCs 
with only linoleic acid; 4) PAMAM dendrimer alone; 5) Crosslinked GNR-NCs.  
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Then, the toxicity of: 1) PTX-loaded GNR-NCs; 2) Crosslinked PTX-loaded GNR-NCs 
and PTX alone will be determined, in particular focusing on the toxicity of the 
conjugates vs free drug. Finally, the effectiveness of the photothermal release will be 
evaluated testing the viability of cell lines after 1) NIR irradiation only; 2) GNR-NCs 
uptake and NIR irradiation; 3) PTX-loaded GNR-NCs uptake and NIR irradiation. We 
will test the effects of these components on cell viability using standard MTT assays. We 
will also use microscopy to observe any morphological changes that may occur during the 
delivery process. Finally, flow cytometry will be used to determine cell mortality, 
information that provides a useful adjunct to viability methods. 
In summary crosslinked NCs are expected to be a safe and nontoxic platform for drug 
delivery and show an externally controlled enhanced drug effect (i.e. cytotoxicity) upon 
laser activation due to drug release, with minimal damage to normal cells from the NIR 
activation. These studies could, then, provide the foundation for future pre-clinical 
animal studies that could lead to an important new therapeutic strategy for tumors. 
!
!
!
!
!
!
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5. Experimental section 
Materials 
Sodium borohydride (>98%), cetyltrimethylammonium bromide (>99%), and silver 
nitrate (99.5%) were purchased from Acros Organics. Chloroauric acid (99.9%) was 
purchased from Strem Chemical, and L-(+)-ascorbic acid was purchased from Alfa Aesar, 
while polysorbate 20 (Tween20), the fourth generation (G4) poly (amido amine) 
(PAMAM) starburst dendrimers, trimethoxysilyl propylene diamine and CS2 were 
purchased from Sigma Aldrich. All chemicals were used as received. Paclitaxel was 
purchased from Polymed Therapeutics. All the solutions were prepared with deionized 
water produced by a Millipore System. 
Synthesis and characterization of gold nanorods 
The synthesis of small sized GNRs was performed following the procedure described in 
Chapter 1. GNRs were characterized through UV-vis spectroscopy and TEM as reported 
in Experimental section of Chapter 1. 
Functionalization of GNRs 
GNRs were functionalized following a two step procedure: in the first step GNRs were 
partially funtionalized with HS-PEG5000, following the procedure by Kinnear et al. [28], 
to provide stability to GNRs during the removal of CTAB and, thereafter, thiol exchange 
with the Arg ligand was performed as follow. 
The amount of ligand was calculated respect to the total surface of the GNRs as follow: 
- The surface of a single GNR was approximated to the surface of a cylinder with two half 
spheres: 
!
were r is the half of the width(w) and l is the length of the GNR. 
- The total surface in the sample used for the functionalization was: 
!
were m is the number of the GNRs moles. 
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- The amount of ligand was calculated to be    
Were MwArginine is the molecular weight of the arginine ligand (535.78 g·mol-1). 
The amount of calculated ligand was dissolved in Milli-Q water, previously purged with 
N2 for 20 minutes; the concentration of the solution was 10mg/ml. The solution of the 
ligand was added drop wise to the washed GNRs in a glass vial with a magnetic stirring 
barr. The sample was kept under N2 and stirred at room temperature for 48 hours. 
Thereafter, Arg-functionalized GNRs were washed as follow: 
Arg-GNRs were placed in centrifuge tubes (0.5ml for each tube) and Milli-Q water (1ml 
for each tube) was added: the result GNRs solution was 3 times diluted. GNRs were then 
centrifuged at a rate of 10630 rpm (12000 g) for 30 minutes for GNRs  with AR of 4.8 
or rpm (13000g) for 40 minutes. The supernatant was removed and the precipitates 
resuspended by the addition of 0.45 ml of Milli-Q water, previously purged with N2. All 
the resuspended GNRs were then mixed together and kept at 4°C in the dark, under N2. 
Characterization of the functionality through LDI-MS  
The LDI-MS analyses were done either on a Bruker Reflex III time-of-flight mass 
spectrometer (Reflex III). Thee spectrometer is equipped with a 337 nm nitrogen laser, a 
1.0-m flight tube, and a  stainless steel sample target. All mass spectra were acquired in 
reflectron mode. Areflectron voltage of 16.1 kV and an accelerating voltage of 20 kV 
were used. An average of 100 laser shots was fired to acquire each spectrum, and the 
typical laser power was 70%, which corresponds to approximately 210 μJ/pulse. A 1 μL 
solution of GNR-NCs (83 nM) in Milli-Q water was applied to target and allowed to air-
dry before LDI-MS. 
Determination of GNRs concentration 
After purification the GNRs concentration was calculated through spectrophotometric 
measurements. 700 μl of milli-Q water were used as reference for the spectrophotometric 
measurement.  
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Then 70 μl of water were removed and 70 μl of washed GNRs were added in the same 
cuvette: the resulting solution was 10 times diluted respect to the washed GNRs. The 
spectrum was recorded between 400 nm and 1000 nm with a 2 nm step. The GNRs 
concentration was then calculated through the Lambert-Beer equation: 
C= A/(ε*l) 
Where C is the concentration (M*l-1), A is the absorbance measured at the maximum of 
the longitudinal LSPR of GNRs, ε is the extinction coefficient calculated (1.15 M-1cm-1) 
and l is the path length (1 cm). The final concentration of the washed GNRs was then 
calculated as 10 times concentrated respect to the concentration obtained from the 
Lambert-Beer equation. 
!
Preparation of GNR-NCs 
To prepare the GNR-NCs, 1.0 μL of linoleic acid was emulsified in 500μL of arginine-
functionalized GNRs (20 μl, 83 nM) in phosphate buffer solution (5.0 mM, pH 7.4) 
using an amalgamator (speed 5000 rpm for 200s).  
This process results oil droplets having 1.58 nM in concentration. Next, 20 μL of the 
1.58 nM droplets were incubated with Arg-GNRs (10 μl, 83 nM) in phosphate buffer 
(5.0 mM, pH 7.4) for 10 min. PTX-loaded GNR-NCs were prepared with the same 
procedure, dissolving PTX in linoleic acid (10 mg/ml) before preparation. The final 
concentration of PTX in the GNR-NCs formulation was 23.4 μM. !
Calculation for NCs concentration 
Concentrations of nanocapsules, both GNR-NCs and crosslinked GNR-NCs were 
calculated as reported by Rotello et al. [8] by setting the diameter of capsules=144nm (for 
GNR-NCs) or 159nm (for crosslinked GNR-NCs).  
!
!
!
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Crosslinking of GNR-NCs 
Crosslinking of GNR-NCs was performed as follow: 
1) 100 μl of CS2 were added into 1.5 ml of DCM, then 1.5 mL of NaOH (1M) were 
added with 1μl of G4 PAMAM dendrimerm (Figure 11) and stirred for two hours; 
2) The dendrimer was taken out from the upper fase; 
3) GNR-NCs were added to the dendrimer solution from 4) at different dendrimer/
GNR ratio: 0.25, 0.50 and 1.00 and shaked overnight. 
4) Finally, crosslinked GNR-NCs were centrifuged for 2 minutes at 2000rpm and 
resuspended in 10 mM PB. 
 
Figure 11. Schematic structure of poly(amido amine) (PAMAM) dendrimer, generation 4 (G4). 
This dendrimer contains 64 amine surface groups and additional 62 amine groups located inside 
the dendrimer structure. [29] !!
UV-vis spectroscopy and DLS measurements 
Optical extinction spectra were recorded between 400 nm and 1000 nm with a step of 2 
nm, using a Molecular Devices SpectraMax M2 plate reader. DLS was performed on a 
zeta potential/particle sizer (Malvern Nano ZS90) to determine the distribution of the 
hydrodynamic diameters of GNR-NCs. Nanocapsules were diluted 10 times in 5 mM PB 
before measurements. !
TEM of GNR-NCs 
GNR-NCs were drop casted onto a 200-mesh carbon-coated copper grid and dried for 
24h. Then TEM images were acquired on a JEOL 7C operating at 80 keV. !!
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Cell viability (Alamar Blue assay) 
Cell Viability (Alamar Blue Assays). [30] HeLa cells were cultured at 37 °C under a 
humidified atmosphere of 5% CO2. The HeLa cells were grown in a low-glucose 
Dulbecco’s modified Eagle’s medium (DMEM, 1.0 g/L glucose) containing 10% fetal 
bovine serum (FBS) and 1% antibiotic (100 U/mL penicillin and 100 μg/mL 
streptomycin). The HeLa cells were maintained in the above medium and subcultured 
once every 4 days. The HeLa cells (6 × 104 cells/well) were seeded in a 24- well plate 24 h 
prior to delivery. On the next day, the old media was removed and the cells were washed 
with a phosphate buffer saline (PBS) three times before NPSC delivery. The cell viability 
was measured using an Alamar Blue assay (Invitrogen, CA). 
Uptake of Nile Red loaded GNR-NCs 
Nile red was dissolved in linoleic acid at a concentration of 1 mg/ml and then used to 
make GNR-NCs. HeLa cells were seeded in 24 well plate at a density of 50000cells/well 
one day prior to the delivery. On the day of the delivery, Hela cells were washed with 
PBS two times, then 20 ul of nile red loaded nanocapsule was suspended with 480 ul 
opti-medium, and added into cells followed by 2 hours incubation. So the final 
concentration of nile red for each well was 25 nM. After 2 hours incubation, cells were 
gently washed with PBS three times, then imagined under green channel using Olympus 
IX51 fluorescent microscope. !
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Summary − Engineering Gold Nanorods for Cancer 
Treatment: Biological Profile, Protein Interactions and Drug 
Delivery. 
!!!!!!
In the present PhD thesis, several issues connected to the synthesis and purification of 
GNRs, as well as to their use have been addressed, with special attention for biomedical 
applications such as protein sensing, the photothermal treatment of cancer, and the 
realization of nanocapsules for the delivery of anticancer drugs.  
In Chapter 1 a method to synthesize GNRs with a size smaller than those obtained with 
the seeded-growth method is illustrated. This novel method consists of an in-situ 
oxidation of GNRs directly during the synthesis through pretreatment of the glass bottle 
used for the synthesis with aqua regia. During the pretreatment the surface of the glass 
container is saturated with NOCl generated from aqua regia. Thereafter, the NOCl 
release from the glass surface promote the oxidation and shortening of GNRs. It is also 
demonstrated that the release-mediated oxidation of GNRs can be interrupted simply 
removing the solution from the treated glass container, allowing a good control of the 
AR and the LSPR of GNRs. Moreover, contrary to other methods, the present synthesis 
can be scaled up and considerable amount of GNRs can be synthesized. In a future work 
this system could be engineered for the production of GNRs in continuos through the 
use of a reservoir of GNRs and pumping nanorods in a treated glass tube. Therefore, the 
control of GNRs flow into the glass tube could provide GNRs with different ARs in a 
large scale. 
Chapter 2 accurately described a modified method for the purification of small GNRs 
from reaction by-products (i.e. spherical and cubic nanoparticles or aggregates). Contrary 
to other methods, the presented one does not require the addition of surfactant or salts 
and large amount of GNRs can be easily separated from by-products with a high yield 
simply by a two-step centrfugation. 
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Chapter 3 concluded that PEGylated GNRs constitute a stable platform for biomedical 
applications. Their shape governs the frequency of their plasmonic resonances, while 
their size can be engineered to optimize the interface with an optical excitation and a 
biological environment for specific uses. The relationship between particle size and some 
biological profiles has been assessed in this chapter, showing that modest PEG-GNRs 
cytotoxicity appears only at high concentrations and after long incubation time, with 
little variations respect to particles size. However some differences may arise from the 
larger specific surface area of smaller particles, which have been associated with some 
contamination originating from the particle synthesis. Acute effects, such as membrane 
permeabilization and haemolysis, were not observed for any particle size. Future efforts 
should  focus on the removal of contaminants from PEG-GNRs without destabilizing the 
PEG coating. The cellular uptake of PEG-GNRs is low and displays some modulation 
with particle size: larger particles may be convenient for those contexts that require 
unspecific uptake, such as for loading of cellular vehicles, while average particles may be 
ideal to inhibit unspecific uptake and pursue slower blood clearance or specificity by the 
addition of ligands. All this evidence, together with the absence of interactions with 
some representative proteins, suggested that PEG-GNRs are compatible with blood 
injection. In essence, particle size does not overturn the safety and blood compatibility of 
PEGylated GNRs in their range of greatest biomedical interest, but may still provide 
alternatives for a fine modulation of functional biological profiles. 
In Chapter 4, the effect of the insertion of charged groups in PEGylated GNRs on 
proteins interaction is reported, by monitoring the LSPR of GNRs, which is highly 
sensitive to changes in the refractive index. A comprehensive view of the reported results 
demonstrated quite unambiguously that the interactions between differently 
functionalized GNRs and a few representative proteins are mainly determined by the 
electrostatic properties of the interacting moieties and, in addition, by the presence of 
electrolytes in solution. These interactions were analyzed in the case of three proteins: 
hCC, HEWL, and BSA. The interactions between the three proteins and the two kinds 
of functionalized GNRs appeared exemplary and clearly supported the Coulombic 
nature of the interaction. The case of the BSA/GNR-PEG-NH2 complexes is the most 
relevant one, which can be schematically depicted as protein adsorption on 
functionalized GNRs followed by partial unfolding. Moreover, the strong influence of 
electrolytes on the interaction between proteins and functionalized GNRs  offers strong 
evidence for the importance of the role of electrostatics in these interactions.  
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In conclusion, this chapter provides demonstrations that the type of functionalization 
can direct quite selectively proteins binding to GNRs, leading to different interaction 
patters and providing useful hints for protein sensing applications. Future work will be 
focused on the use of this method for sensing on a solid substrate through 
immobilization of functionalized GNRs on a surface. 
!
Finally, Chapter 5 reported the integration of the controlled release properties of the 
GNP-NCs systems with the NIR capabilities of GNRs, which could provide drug delivery 
systems with highly spatiotemporal therapeutic action. Therefore, the strategy to 
develope GNP-NCs has been adapted to produce GNR-stabilized NCs with a size 
suitable to take advantage of the EPR effect. GNR-NCs have also been crosslinked with 
G4 PAMAM dendrimer to provide NCs that are stable in physiological conditions. 
Moreover, crosslinked GNR-NCs have been designed to be safe platforms for delivery 
and to promote the PTX release upon laser activation. In fact, nanocapsules did not 
show potential nonspecific NCs cytotoxicity on HeLa cells, while PTX-loaded crosslinked 
nanocapsules showed a different cytotoxicity profile compared to PTX-loaded GNR-NCs, 
suggesting that crosslinking may inhibit PTX release. Further studies will be performed 
to characterize the potential PTX photorelease in solution and the in vitro effectiveness 
of the photorelease against HeLa cells. These GNR-stabilized nanocapsules could provide 
highly localized release of anticancer therapeutics, laying the basis for future pre-clinical 
animal studies that could lead to an important new therapeutic strategy for tumors. 
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